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Lacking colonic mucosal innervation correlated with
increased inflammatory immune cell status, microbial dys-
biosis, and higher incidence of postoperative enterocolitis in
HSCR patients. Mucosal nerve fibers might serve as a
prognostic marker for enterocolitis development and offer
new therapeutic intervention strategies.
BACKGROUND & AIMS: Hirschsprung’s disease (HSCR) is a
congenital intestinal motility disorder defined by the absence of
enteric neuronal cells (ganglia) in the distal gut. The
development of HSCR-associated enterocolitis remains a life-
threatening complication. Absence of enteric ganglia impli-
cates innervation of acetylcholine-secreting (cholinergic) nerve
fibers. Cholinergic signals have been reported to controlexcessive inflammation, but the impact on HSCR-associated
enterocolitis is unknown.
METHODS: We enrolled 44 HSCR patients in a prospective
multicenter study and grouped them according to their degree
of colonic mucosal acetylcholinesterase-positive innervation
into low-fiber and high-fiber patient groups. The fiber pheno-
type was correlated with the tissue cytokine profile as well as
immune cell frequencies using Luminex analysis and
fluorescence-activated cell sorting analysis of colonic tissue and
immune cells. Using confocal immunofluorescence microscopy,
macrophages were identified in close proximity to nerve fibers
and characterized by RNA-seq analysis. Microbial dysbiosis was
analyzed in colonic tissue using 16S-rDNA gene sequencing.
Finally, the fiber phenotype was correlated with postoperative
enterocolitis manifestation.
RESULTS: The presence of mucosal nerve fiber innervation
correlated with reduced T-helper 17 cytokines and cell
508 Keck et al Cellular and Molecular Gastroenterology and Hepatology Vol. 12, No. 2frequencies. In high-fiber tissue, macrophages co-localized with
nerve fibers and expressed significantly less interleukin 23
than macrophages from low-fiber tissue. HSCR patients lacking
mucosal nerve fibers showed microbial dysbiosis and had a
higher incidence of postoperative enterocolitis.
CONCLUSIONS: The mucosal fiber phenotype might serve as a
prognostic marker for enterocolitis development in HSCR pa-
tients and may offer an approach to personalized patient care
and new therapeutic options. (Cell Mol Gastroenterol Hepatol
2021;12:507–545; https://doi.org/10.1016/j.jcmgh.2021.03.004)
Keywords: Enterocolitis; Neuroimmunology; Cholinergic Nerve
Fibers; Macrophages; Th17 Cells; Microbiome.See editorial on page 785.
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https://doi.org/10.1016/j.jcmgh.2021.03.004Hcongenital malformation of the colon characterized
by a distal lack of enteric ganglia cells (aganglionosis)
leading to intestinal obstruction and prestenotic megacolon.
In affected infants, the aganglionic bowel is surgically
removed, and healthy ganglionic tissue is pulled through
and reconnected near the anus. Either preoperatively or
postoperatively, 20%–50% of patients experience life-
threatening HSCR-associated enterocolitis leading to acute
abdominal distention, diarrhea, and fever through to sepsis
and organ failure.1 The underlying pathogenesis is not fully
understood but appears to involve changes in intestinal
barrier function,2 immune response,3 and the microbiome.4
The absence of ganglia from the distal colon in HSCR is
associated with an increase in acetylcholinesterase (AChE)
activity concomitant with hypertrophic AChE-positive nerve
fibers.5–14 AChE degrades the neurotransmitter acetylcho-
line (ACh), the primary transmitter of the parasympathetic
nervous system and a neurotransmitter released by many
types of enteric neurons.
Intestinal cholinergic (ACh-producing) signals not only
coordinate physiological bowel function but also prevent
excessive inflammation by allowing the intestinal immune
system to tolerate harmless commensals and food antigens.
The cholinergic anti-inflammatory pathway (CAIP) was first
described by the Tracey group.15 In a model of systemic
inflammation, vagus nerve (VN) stimulation favored the
release of ACh by memory T cells, which in turn bound to a7-
nicotinic ACh receptor (a7nAChR)-positive splenic macro-
phages (MF) to reduce tumor necrosis factor (TNF)-a pro-
duction.15,16 This concept was confirmed in intestinal
inflammation models involving colitis,17 food allergy,18
postoperative ileus (POI),19 and pancreatitis using VN stim-
ulation or pharmacologic targeting of a7nAChR. In humans,
nicotine, which activates nAChRs, has been associated with
clinical improvement of ulcerative colitis.20 VN stimulation in
Crohn’s disease results in amelioration of disease activity and
is a subject of ongoing therapeutic evaluation.21–23 Contrary
to systemic CAIP, intestinal modulation is independent of the
spleen and involves direct activation of local entericneurons.19 Although VN activation leads to down-regulation
of inflammatory cytokine production by muscularis MF
(MMF) via a7AChR activation in POI, it remains unclear
which receptors and cell types are involved in colitis
amelioration. Because the enteric nervous system (ENS) uses
more than 30 different neurotransmitters, it is challenging to
identify individual immune-modulating functions. Because of
the lack of ENS-specific neurotransmitters and the presence
of hypertrophic AChE-positive nerve fibers in the aganglionic
colon of HSCR patients, neuronal cholinergic function can be
examined particularly well.
Here we investigated the association of mucosal cholin-
ergic innervation with immune cell status, microbial
composition, and development of postoperative enteroco-
litis in HSCR patients.Results
Distinct Mucosal Cholinergic Innervation of the
Colon in HSCR Patients
In this prospective, multicenter study, we collected fresh
tissue of different colonic segments from 44 pediatric HSCR
patients undergoing pull-through surgery as well as 6 con-
trol patients (non-HSCR) undergoing surgery for miscella-
neous reasons. Compared with non-HSCR colonic tissue, the
aganglionic colon of HSCR patients lacks the intrinsic
myenteric and submucosal plexus but shows the charac-
teristic increase of AChE activity in the rectosigmoid
(Figure 1A). Increased nerve fiber innervation is limited to
the aganglionic rectosigmoid colon and decreases in a cau-
docranial direction.5 As a consequence, no mucosal nerve
fibers can be detected in the proximal aganglionic
descending colon (DC) and only a few in the intermuscular
space. Depending on the length of aganglionosis, the prox-
imal DC segment of HSCR patients can be ganglionic,
hypoganglionic, or aganglionic (Figure 1A, Table 1). DC
segments showing a hypoganglionic phenotype (transition
zone) were excluded from the analysis.
A
B C
Figure 1. Distribution of
neuronal innervation and fi-
ber scoring of HSCR pa-
tients. (A) Schematic
representation of neuronal
innervation in non-HSCR and
HSCR patients. Immunohisto-
chemical anti-b3tubulin stain-
ing of ganglionic DC region
(non-HSCR) or anti-AChE
staining of aganglionic rectum
region (HSCR). Scale bar: 50
mm. (B and C) Anti-b3tubulin
immunohistochemical staining
of Swiss roll cryosections from
HSCR fiber-low phenotype (B)
and fiber-high phenotype (C).
Close-up views show mucosal
region from 1, rectum; 2, sig-
moid colon; and 3, descending
colon. Scale bar: 2 mm; Scale
bar close-up views: 20 mm.
2021 Neuroimmune Association in HSCR Patients 509We performed anti-b3tubulin immunohistochemistry
staining (pan neuronal marker) in aganglionic cryosections
of longitudinally rolled colonic stripes (Swiss roll), including
the rectum, sigmoid colon, and DC from HSCR patients.All patients’ tissues showed the typical thick nerve fiber
bundles in the colonic muscle region,24 but the density of thin
mucosal fibers varied between patients25 (Figure 1B and C).
No mucosal nerve fibers could be detected in the aganglionic

























Laxative (1); Clyster (2);





0002 F 6.6 abdominal
Swenson
01 HSCR TCA low x 1,2,3,4 1,2,4,5,6
0004 M 6.7 transanal Soave 02 HSCR S-HSCR low no no
0005 M 127.5 transanal Soave 10 HSCR S-HSCR low 2,3,4 1,4,5
0006 F 4.3 transanal Soave 10 HSCR S-HSCR low 1 1
0010 M 3.9 transanal
Swenson
07 HSCR S-HSCR high no no
0012 M 4.9 transanal
Swenson
09 HSCR L-HSCR high x 1 1,2
0013 M 6.9 transanal
Swenson
07 HSCR S-HSCR low no no
0014 M 3.9 transanal Soave 10 HSCR S-HSCR low x 3 4
0015 F 2.8 transanal Soave 01 HSCR S-HSCR low x no no
0016 M 3.2 transanal Soave 10 HSCR S-HSCR high no 4
0017 M 5.9 abdominal
Soave
09 HSCR TCA low x no no
0018 M 3.2 transanal Soave 10 HSCR S-HSCR high x no 4
0020 M 11.8 transanal Soave 07 HSCR L-HSCR low x no no
0021 M 23.5 transanal Soave 04 HSCR S-HSCR low 1 2
0022 M 7.2 abdominal
Soave
09 HSCR TCA low x no 4
0023 F 14.2 transanal Soave 04 HSCR S-HSCR low x
0025 M 3 transanal Soave 10 HSCR S-HSCR high x no 4
0029 M 10.1 transanal Soave 09 HSCR L-HSCR high x 2,4 no
0032 M 35.9 transanal Soave 04 HSCR S-HSCR high x
0034 M 2.9 abdominal
Soave
06 HSCR TCA low x no no
0038 M 19.2 abdominal
Soave
10 HSCR TCA low x no no
0039 M 12.5 transanal Soave 09 HSCR S-HSCR low 4 no
0040 M 3.8 transanal Soave 02 HSCR S-HSCR low no no
0041 M 5.9 transanal Soave 03 HSCR L-HSCR low x 1 1
0042 M 2.2 transanal Soave 06 HSCR S-HSCR low 1,3 1,3,4,5
0044 M 13.6 transanal Soave 03 HSCR S-HSCR low x no no
0047 M 44.5 transanal Soave 02 HSCR S-HSCR high 2 no
0048 M 3.8 transanal Soave 07 HSCR S-HSCR low 1 3,5
0049 M 70.5 transanal Soave 10 HSCR S-HSCR low x no 4
0050 M 5.7 transanal Soave 10 HSCR L-HSCR low no no
0051 M 2.5 transanal Soave 08 HSCR S-HSCR low 3 no






































Laxative (1); Clyster (2);
Botox (3); Antibiotics (4);
Colonic irrigation (5);
Pre-/probiotics (6)
0054 F 6.1 transanal Soave 10 HSCR S-HSCR low no no
0056 M 4.2 transanal Soave 08 HSCR S-HSCR high x 1 1
0057 F 7.7 transanal Soave 08 HSCR S-HSCR high 1,3 1,4,5,6
0058 M 5.7 transanal Soave 08 HSCR S-HSCR high x 3 4,5
0059 M 5 transanal Soave 10 HSCR S-HSCR low no no
0060 M 5 abdominal
Soave
10 HSCR TCA high x 4 5
0061 M 2.8 transanal Soave 02 HSCR S-HSCR low 1 1
0063 M 3.8 transanal Soave 08 HSCR S-HSCR low x 3,4 1,4,5
0064 F 64 abdominal
Soave
01 HSCR TCA low x no 4
0065 F 34.5 transanal Soave 09 HSCR S-HSCR low no no
0066 F 5.3 transanal Soave 01 HSCR L-HSCR low x no 6
0068 M 3.9 transanal Soave 09 HSCR S-HSCR high x no no
Non-HSCR
patients
0024 M 0.4 transabdominal 01 Anal atresia/
Ostomy
x
0030 M 7 transabdominal 06 Anal atresia/
Ostomy
x
0037 M 5 transabdominal 01 Anal atresia/
Ostomy
x
0062 M 5.9 transabdominal 01 Anal atresia/
Ostomy
x
0067 F 6.8 transabdominal 01 Colonic perforation/
Ostomy
x
0045 M 11.9 transabdominal 10 Misdiagnosed
HSCR
x
NOTE. Site of operation: Basel 01; Bern 02; Düsseldorf 03; Freiburg 04; Heidelberg 06; Karlsruhe 07; Lausanne 08; St Gallen 09; Zürich 10.












Figure 2. Fiber innervations grades for fiber scoring. (A) AChE immunohistochemistry of 5-mm cryosections of distal
aganglionic colon showing 4 different mucosal innervation grades. Grades 1 and 2 were grouped into fiber-low and 3 and 4
were grouped into fiber-high HSCR patients. (B) Using brightfield microscopy and CellSens Dimension Software, the inner-
vation grade was quantitatively confirmed in 3 representative patients per group. Scatter dot plots show means ± standard
error of the mean. Scale bar: 50 mm
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innervation in the distal rectosigmoid colon, the sections
were semiquantitatively allocated into low-fiber (Figure 1B)
and high-fiber (Figure 1C) patient groups in a double-blind
investigation. The fiber innervation grade was quantita-
tively confirmed in 3 representative patients per group
(Figure 2). Fiber phenotype was validated using both anti-
AChE and anti-b3tubulin immunohistochemistry (Figure 3).Consequently, for further analysis, aganglionic and gangli-
onic segments with variable mucosal nerve fiber innervation
were defined as illustrated by anti-b3tubulin and anti-AChE
immunofluorescent staining (Figure 4A). Thus, rec-
tosigmoid low-fiber tissues were those lacking intrinsic
nerve cell bodies as well as mucosal AChEþ innervation.
Rectosigmoid high-fiber tissues were those lacking intrinsic
nerve cell bodies but showing mucosal AChEþ innervation
A
B
Figure 3. Fiber scoring of distal colon of
HSCR patients using tubulin and AChE
immunohistochemistry. Tubulin and AChE
immunohistochemistry of 5-mm cry-
osections of distal aganglionic colon of 2
fiber-high (A) and 2 fiber-low (B) HSCR
patients. Scale bar: 50 mm.
2021 Neuroimmune Association in HSCR Patients 513(Figure 4A). Aganglionic DC sections from HSCR patients
were defined as those lacking intrinsic nerve cell bodies as
well as mucosal AChEþ innervation. Ganglionic DC sections
from HSCR and non-HSCR patients showed the presence ofAChE- mucosal nerve terminals (Figure 4A) and AChEþ nerve
cell bodies (ganglia) (Figure 4B, positive control). DC seg-
ments (aganglionic and ganglionic) were used from both low-
fiber and high-fiber patient tissue.
514 Keck et al Cellular and Molecular Gastroenterology and Hepatology Vol. 12, No. 2Former studies reported non-neuronal expression of
ACh in intestinal epithelial cells.26,27 Although secondary
antibody controls showed high unspecific backgroundA
B
C
signals in the epithelial crypt region (Figure 4B, negative
control), a strong epithelial AChE reactivity was detected in
































Figure 5. AChE expression in colonic epithelial cells. After
tissue digestion colonic epithelial cells were purified from the
interphase of 20% and 40% Percoll Gradient. Epithelial cells
were immediately lysed, total RNA was isolated, and cDNA
was synthesized. Relative gene expression was calculated
using the 2-DCT method, with b2-microglobulin as the
housekeeping gene. Scatter plots with bar show means ±
standard error of the mean. Significance was determined by
multiple comparison using one-way analysis of variance.
Fiber-low, n ¼ 27; fiber-high, n ¼ 13; DC (AG), n ¼ 10; DC (G),
n ¼ 11; DC control, n ¼ 6. AG, aganglionic; G, ganglionic.
2021 Neuroimmune Association in HSCR Patients 515quantitative real-time polymerase chain reaction (qRT-PCR)
analysis of purified colonic epithelial cells from HSCR pa-
tients and control patients, no significant difference in AChE
expression could be observed between the different groups
(Figure 5). To confirm a cholinergic origin of the mucosal
nerve fibers we performed immunofluorescence staining
using tubulin and vesicular acetylcholine transporter
(VAChT), the transporter making ACh available for secretion
(Figure 4C). Immunofluorescence studies in high-fiber tis-
sue excluded peptidergic (vasoactive intestinal peptide
[VIP]), dopaminergic/adrenergic (tyrosine hydroxylase
[TH]), and nitrinergic (nitric oxide synthase [NOS]) origins
of the mucosal fibers and demonstrated that the majority of
mucosal fibers were not associated with the glia cell marker
S100B (Figure 6A). All markers were expressed in myen-
teric ganglia from ganglionic DC tissue (Figure 6B).
We did not observe any significant patient bias in terms
of anthropometric, clinical, environmental, or maternalFigure 4. (See previous page). Cholinergic innervation in d
epithelial/mucosal region from aganglionic and ganglionic co
(Alexa647, green) and AChE (Cy3, red). DAPI (blue) shows cell
bar: 50 mm. DC control images: scale bar: 100 mm. DC AG: agan
DC control: ganglionic descending colon from control patients.
ganglia from ganglionic control tissue. Negative control: immun
fiber-high colonic tissue using secondary antibody controls mo
Scale bar: 50 mm. (C) Immunofluorescence of epithelial/muco
tissue from HSCR patients using tubulin (Alexa647, green) and
areas mark the epithelial crypt/lumen. Positive control: immun
control tissue. Scale bar: 50 mm. Negative control: immunofluo
high colonic tissue using secondary antibody controls mouse Igfactors between low-fiber and high-fiber tissues, except a
higher percentage of infants delivered by cesarean section
in the high-fiber patient group (Table 2).Absence of Neuronal Signals Correlated With
Inflammatory Immune Status
A functional ENS is crucial for intestinal immune ho-
meostasis. To investigate whether the absence of enteric
neuronal cells and/or nerve fibers correlated with impaired
inflammatory cytokine status in HSCR patients, we per-
formed Luminex (Austin, TX) analysis of full-thickness
colonic tissue (mucosa, submucosa, muscle) from HSCR
patients and control patients.
Interleukin (IL) 17 was significantly less abundant in
mucosal innervated high-fiber tissue samples compared
with aganglionic DC samples (Figure 7A). In aganglionic DC
samples, IL6 and IL1b were increased compared with
ganglionic DC samples as well as aganglionic high-fiber
samples. IL22, IL23, and interferon-g proteins were
comparably expressed in the different groups, whereas
TNF-a was significantly elevated in aganglionic compared
with ganglionic HSCR DC samples (Figure 7A). In summary,
we found elevated levels of inflammatory cytokines in
aganglionic DC samples lacking enteric neurons as well as
AChEþ nerve fibers. This elevation was decreased in
ganglionic DC samples for IL6 and IL1b and in aganglionic
high-fiber samples for IL17, IL6, and IL1b, all of which are
involved in CD4 Rorgtþ T-helper 17 (Th17) cell differenti-
ation and effector function.
Beside innate lymphoid cells (ILC) 3 and others, Th17
cells are the main producers of IL17 and are counter-
regulated by forkhead box P3 positive (Foxp3þ) regulato-
ry T cells (Treg). Frequencies of mucosal IL17þ, Th17, and
Foxp3þ Treg T cells were assessed by flow cytometry. Th17
frequencies were significantly increased in low-fiber seg-
ments compared with high-fiber segments or DC segments
(Figure 7B, Figure 8A). We observed no difference between
aganglionic and ganglionic DC tissue of HSCR and control
patients. Foxp3þ Treg cell frequencies were significantly
elevated in cholinergic innervated high-fiber tissues
compared with aganglionic and ganglionic DC samples
(Figure 7C). Accordingly, the ratio of Th17/Treg cell fre-
quencies was significantly higher in low-fiber segments
compared with high-fiber segments (Figure 7D). Fre-
quencies of natural killer (NK) cell receptors (NCR)þ and
NCR- ILC3 were comparable between the different colonicistal colon of HSCR patients. (A) Immunofluorescence of
lonic tissue from HSCR and control patients using tubulin
nuclei. Encircled areas mark the epithelial crypt/lumen. Scale
glionic descending colon; DC G: ganglionic descending colon;
(B) Positive control: immunofluorescence of myenteric plexus
ofluorescence of epithelial/mucosal region from aganglionic
use IgG2b-biotin/SA-Cy3 together with mouse IgG2a-A647.
sal region from aganglionic fiber-low and fiber-high colonic
VAChT (A555, red). DAPI (blue) shows cell nuclei. Encircled
ofluorescence of myenteric plexus ganglia from ganglionic
rescence of epithelial/mucosal region from aganglionic fiber-




analysis of fiber-high HSCR tis-
sue for neuronal marker. (A)
Immunofluorescence (5-mm Swiss
roll cryosections) of aganglionic
rectum region from a fiber-high
patient using tubulin (Alexa647,
green), a general neuronal marker,
combined with VIP (A555, red), la-
beling peptidergic neurons; TH
(A555, red), labeling dopaminergic
and adrenergic neurons; NOS
(A555, red), labeling nitrinergic
neurons, and S100B (S100
calcium-binding protein B; A555,
red), labeling glia cells. DAPI (blue)
shows cell nuclei. Images were
taken by fluorescence microscopy
(original magnification, 20; scale
bar, 100 mm) and processed by Fiji
software. Close-up views (white
boxes) show mucosal/epithelial
region. Negative control: immuno-
fluorescence (5-mm Swiss roll cry-
osections) of aganglionic rectum
region from a fiber-high patient
using secondary antibody controls.
(B) Immunofluorescence of myen-
teric plexus ganglia from gangli-
onic control tissue using the
antibody combinations from (A).
Scale bar, 50 mm; scale bar for
NOS images, 30 mm.
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innervation in distal low-fiber tissue is associated with
increased Th17 cell frequencies and a higher ratio of Th17/
Treg cell frequencies.CX3C chemokine receptor 1þ (CX3CR1þ) MF represent
the major antigen-presenting cell (APC) type in the colon
and are crucial for CD4 T-helper cell differentiation. These
MF exhibit a non-inflammatory M2-like phenotype and are
Table 2.Characteristics of Prospective HSCR Patient Cohort
Anthropometric data and potential risk
factors (no. of patients followed up)
No. patients positive for risk factor/




(n ¼ 13) P value
Age at operation, mo (n ¼ 44) 5 [1–127] 5 [1–127] 4 [3–44] .678
Sex, male (n ¼ 44) 35/44 (80) 23 (74) 12 (92) .174
Preterm birth (n ¼ 40) 3/40 (8) 1 (4) 2 (18) .114
Pets (n ¼ 41) 13/41 (32) 9 (33) 4 (33) 1.000
Patient living in rural area (n ¼ 42) 21/42 (50) 15 (50) 6 (50) 1.000
Antibiotic treatment (n ¼ 40) 5/40 (13) 4 (15) 1 (8) .602
Siblings (n ¼ 41) 32/41 (78) 21 (72) 11 (92) .175
Breastfed at operation (n ¼ 41) 38/41 (93) 27 (90) 11 (100) .276
Maternal age at delivery, y (n ¼ 37) 28 [21–43] 30 [23–43] 28 [21–35] .111
Parental smoking (n ¼ 40) 9/40 (13) 5 (18) 4 (33) .283
Cesarean section (n ¼ 40) 14/40 (35) 7 (25) 7 (58) .043
Maternal allergy (n ¼ 40) 11/40 (28) 7 (25) 4 (33) .685
NOTE. Values are median [range] or number (percentage %).
2021 Neuroimmune Association in HSCR Patients 517essential for local expansion and maintenance of Treg.28 In
contrast, intestinal C-C chemokine receptor type 2þ (CCR2)
CX3CR1 blood-monocyte-derived MF are essential for Th17
cell differentiation.29,30 We performed qRT-PCR analysis in
full-thickness and colonic muscle tissue to check for
expression of CX3CR1 and CCR2. In high-fiber tissue as well
as in colonic muscle tissue, we found a significantly higher
expression of CX3CR1 than CCR2, whereas in all other
segments expression levels of the 2 markers were compa-
rable (Figure 8C). We next investigated viable CD64þ MF by
flow cytometry. All MF expressed comparable levels of
CD11c (Figure 7E). However, we found a significantly higher
expression of CD14, an M2 marker,31 in MF isolated from
the mucosal lamina propria (LPMF) of high-fiber colonic
tissue and in MF isolated from MMF (Figure 7E). MMF
interact with neurons of the myenteric plexus and have
been described as bipolarly shaped.32–34 Using confocal
fluorescence microscopy, we visualized the bipolar shape of
LPMF in high-fiber segments similar to that seen with MMF
(Figure 7F, left and right images). In contrast, LPMF in low-
fiber colonic segments exhibited a round or stellate
phenotype (Figure 7F, middle image). We found a signifi-
cantly higher percentage of bipolar MF in high-fiber colonic
tissue (Figure 7F, bar graph).
We attempted to mimic the phenotype of the 2 colonic
macrophage populations by differentiating blood-derived
monocytes from healthy adult donors into M1 and M2
MF. After 10 days of differentiation, M2 MF showed an
elongated bipolar shape (Figure 8D and E) and increased
expression of CD14 and CX3CR1 (Figure 8F and G). In
contrast, M1 MF exhibited a rounded shape and expressed
moderate levels of CD14 while lacking CX3CR1 expression.
To test the ability of the MF to differentiate T cells into
certain effector T cells, we co-cultured M1 and M2 MF with
autologous naive CD4 T cells in the presence of anti-CD3
and performed a Th17 and Treg T-cell differentiation
assay. After 6 days of co-culture, the frequency of Th17 and
Treg cells was analyzed, and the ratio was calculated. Th17/Treg ratio was significantly lower when co-cultured with
bipolar CX3CR1þ CD14high M2 MF (Figure 8H). These ob-
servations suggested that high-fiber segments of HSCR colon
harbor mainly a bipolar CD64þ CD11cþ CD14high MF pop-
ulation in the mucosa possibly associated with decreased
Th17 cell frequencies.Bipolar CD14high MF Co-localized With AChEþ
Nerve Fibers
Both MF and T cells express receptors for neurotrans-
mitters, qualifying them for neuronal interaction.19,32,33,35,36
Representative fluorescence images (20 and 63) of high-
fiber and low-fiber rectosigmoid colonic tissue revealed
CD64þ MF and CD3þ T cells in close proximity to AChEþ
fibers (Figure 9A). In the colonic muscle layer, MF were
detected between fasciculated AChEþ fiber bundles. To
determine which cell type could physically interact with thin
mucosal nerve fibers, we performed fast-scanning confocal
imaging using a Fiji software macro to determine the sum of
overlapping pixel values (Figure 9B, Supplementary Video
1). Per patient (low-fiber segments, n ¼ 4; high-fiber seg-
ments, n ¼ 5; muscle, n ¼ 2), 100–200 CD64þ or CD3þ cells
were annotated, and the sum of overlapping AChEþ pixel
values was determined. The results showed that AChEþ fi-
bers in high-fiber tissue as well as colonic muscle segments
preferentially co-localized with CD64þ LPMF in contrast to
CD3þ T cells (Figure 9C). Using triple immunofluorescence
staining against CD64, AChE, and tubulin, we showed that
LPMF from high-fiber tissue were associated with neuronal
tubulinþ AChEþ fibers rather than non-neuronal tubulin-
AChEþ cells (Figure 10A and B). LPMF from ganglionic DC
tissue from HSCR and control patients seemed to be asso-
ciated with tubulinþ AChE- neurons (Figure 10B), which is
consistent with recent reports.33,37 These results suggested
that bipolar LPMF were closely associated with thin
mucosal AChEþ fibers in aganglionic high-fiber tissue from
HSCR patients.
Figure 7. Cytokine profile and
immune cell status in colon of
HSCR patients. (A) Luminex
analysis of full-thickness
colonic tissue isolated from
different aganglionic (AG) and
ganglionic (G) colonic seg-
ments of HSCR and control
patients. IL23 was determined
by enzyme-linked immunosor-
bent assay. Fiber-low (n ¼ 30);
fiber-high (n ¼ 13); AG DC (n ¼
12); G DC (n ¼ 12); control DC
(n ¼ 5). IL23 protein expression
was not detectable in 5 fiber-
low, 3 fiber-high, 3 aganglionic
DC, 5 ganglionic DC, and 3
control DC samples. (B–E)
FACS analysis of mononuclear
cells isolated from different
aganglionic and ganglionic
colonic segments of HSCR and
control patients. Frequencies of
IL17þ Th17 T cells (B),
CD127-Foxp3þ Treg cells (C).
Fiber-low (n ¼ 30); fiber-high
(n ¼ 13); AG DC (n ¼ 10); G
DC (n ¼ 10); control DC (n ¼ 5).
(D) Ratio Th17/Treg cells. (E)
Frequencies of CD11cþ and
CD14þ MF. Fiber-low (n ¼ 26);
fiber-high (n ¼ 13); AG DC (n ¼
10); muscle (n ¼ 10); G DC (n ¼
10); control DC (n ¼ 5). (F)
Immunofluorescence of CD64þ
MF from a colonic muscle re-
gion (left), a mucosal region
from a fiber-low patient (center),
and a mucosal region from a
fiber-high patient (right). Scale
bar: 10 mm and 30 mm (muscle).
Images from 3 fiber-high and 3
fiber-low patients were
analyzed for MF shape. A total
of 100–200 CD64þ cells per
patient were counted, and the
percentage of bipolar cells was
calculated (bar graph). Scatter
plots (with and without bars)
show means ± standard error
of the mean. Significance was
determined using one-way
analysis of variance multiple
comparison analysis (A–F) and
an unpaired nonparametric
Mann-Whitney test (*P  .05;
**P  .01; ***P  .001). Table 10
shows P values. Figure 15
shows the FACS gating
strategy.
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Express Diminished IL23 Levels
To identify specific genes potentially targeted by
neuronal interaction, we performed RNA sequencing inviable fluorescence-activated cell sorting (FACS)-sorted
mucosal MF (CD45þ HLAþ CD64þ) isolated from low-fiber
and high-fiber tissues. As control, we included MMF as well
as in vitro–differentiated blood-derived M1 and M2 MF.
Figure 8. Immune cell populations in colonic tissue from HSCR and control patients and in vitro T-cell conversion
assay. (A) Flow cytometric analysis of mononuclear cells isolated from different aganglionic and ganglionic colonic segments
of HSCR and control patients. Frequencies of total cells are shown. IL17þ Th17 T cells were gated in viable CD3þ CD4þ
lymphocytes restimulated with PMA/ionomycin. Treg cells were defined as CD127- Foxp3þ cells in unstimulated viable CD3þ
CD4þ lymphocytes. Fiber-low (n ¼ 30); fiber-high (n ¼ 13); AG DC (n ¼ 10); G DC (n ¼ 10); control DC (n ¼ 5). CD14þ MF were
gated in viable HLAþ CD64þ cells. Fiber-low (n ¼ 26); fiber-high (n ¼ 13); AG DC (n ¼ 10); muscle (n ¼ 10); G DC (n ¼ 10);
control DC (n ¼ 5). Exact P values indicated in Table 10. (B) Frequencies of NCRþ (Nkp44þ) and NCR- (Nkp44-) ILC3 (CD117þ)
subsets. Fiber-low (n ¼ 17); fiber-high (n ¼ 9); AG DC (n ¼ 6); G DC (n ¼ 6); control DC (n ¼ 3). Figure 15 shows flow cytometric
gating strategy. Scatter plots with bar show means ± standard error of the mean. Significance was determined by multiple
comparison using one-way analysis of variance (*P  .05; **P  .01, ***P  .001, ****P  .0001); exact P values indicated in
Table 10. (C) Quantitative RT-PCR analysis of full-thickness colonic tissue or isolated muscle tissue from different aganglionic
and ganglionic colonic segments of HSCR and control patients (CX3CR1, circles and CCR2, squares). Significance was
determined by using Wilcoxon matched-pairs signed-rank test. Fiber-low (n ¼ 31); fiber-high (n ¼ 13); AG DC (n ¼ 12); G DC
(n ¼ 11); control DC (n ¼ 5). (D and E) Representative brightfield microscopic images (original magnification, 10) of M2 (D) and
M1 (E) after 10 days of differentiation. Scale bar: 20 mm. (F and G) Flow cytometric analysis of blood-derived M1 and M2
macrophages from adult healthy donors. Histograms show CD14 (F) and CX3CR1 (G) expression in M1 (green) and M2 (blue)
macrophages as well as in unstained controls (filled histograms). Representative analysis out of 3 independent experiments is
shown. (H) Th17 and Treg conversion assay using blood-derived M1 and M2 macrophages. Frequencies of Th17 and Treg
cells were determined, and Th17/Treg ratio was calculated. One out of 3 independent experiments is shown. Significance was
determined using unpaired t test. Figure 15 indicates FACS gating strategy.
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520 Keck et al Cellular and Molecular Gastroenterology and Hepatology Vol. 12, No. 2Principal component analysis (PCA) showed transcriptional
separation of blood-derived MF from colonic patient-
derived MF (Figure 11A). Macrophage-specific genes
(CD64, CD14, ITGAM, CX3CR1, CCR2, ITGAX, and CSF1R)
were similarly expressed between colonic populations,
whereas MMF expressed muscle-specific Lyve1A
B C
D
(Figure 11B).38 When testing for gut-specific M2 markers
(AhR, CD200R1, AREG, CD209, TGF-b2, and IL10), we found
elevated expression in colonic subsets similar to blood-
derived M2 MF. In contrast to LPMF from low-fiber seg-
ments, LPMF from high-fiber tissue as well as MMF
showed, by trend, decreased expression of chemokine
2021 Neuroimmune Association in HSCR Patients 521receptor CCR7 crucial for lymph node homing, indicating a
tissue-resident population (Figure 11B). Differential gene
expression analysis yielded 24 significantly changed genes
between LPMF isolated from low-fiber and high-fiber
colonic tissues (Figure 11C and D). Strikingly, IL23a, a
subunit of the Th17-inducing cytokine IL23, was signifi-
cantly lower in LPMF isolated from high-fiber compared
with low-fiber segments. We found a lower expression of
IL6 and CCL-20, both of which are involved in Th17 dif-
ferentiation and recruitment, but comparable TNF-a
expression in LPMF isolated from high-fiber compared with
low-fiber segments (Figure 11E).
Using immunofluorescence analysis, we quantitatively
analyzed IL23 protein expression in CD64þ LPMF in cry-
osections from low-fiber and high-fiber colonic tissue
(Figure 11F and G). LPMF in 4–8 regions per patient were
analyzed and quantified using CellProfiler software. Low-
fiber colonic tissue showed significantly increased fre-
quencies of IL23-positive LPMF compared with high-fiber
colonic tissue (Figure 11H).
This result suggested that LPMF isolated from cholin-
ergic innervated high-fiber colonic tissue exhibited an anti-
inflammatory, tissue-resident phenotype with decreased
expression of the Th17-inducing cytokine IL23 compared
with LPMF isolated from low-fiber tissue. Of note, RNA-seq
analysis was limited by low sample numbers and high
variance and thus needs further validation.Distinct Expression of Macrophage-Specific
Transcripts
Next, we aimed to identify receptors and proteins
possibly involved in the neuronal modulation of LPMF. On
the basis of transcriptional analysis of FACS-sorted mucosal
MF, we verified the expression of receptors for neuro-
transmitters, neuropeptides, neurotrophic factors, and axon-
guidance proteins (Figure 12). We found a tendency toward
elevated levels of nicotinic (CHRNA7, CHRNA5, CHRNA1)
and muscarinic (CHRM3) receptors in LPMF isolated from
high-fiber compared with LPMF isolated from low-fiber
HSCR tissue (Figure 12A and F). In contrast, other re-
ceptors reported to be involved in cholinergic immune
suppression such as receptors for serotonin,39 catechol-
amine (ADRB2),33 or neuropeptides (NMUR1, VIPR1, SSTR2,
and CALCRL)40–43 were either not up-regulated in high-fiberFigure 9. (See previous page). CD64D LPMF co-localize with
cryosections of representative fiber-high and fiber-low patients
Scale bar: 10 mm (original magnification, 63 images) and 30
nofluorescence image of an intercrypt region from a fiber-high p
Z-projection image. Scale bar: 7 mm. See Supplementary Video
or CD3þ T cells and AChE using a Fiji software macro. Confocal
CD64; n ¼ 3 for CD3) and fiber-high (n ¼ 5 for CD64; n ¼ 3 for C
patients (n ¼ 2) were taken. The following negative staining c
streptavidin-Cy3 and IgG1-A488 þ biotin/streptavidin-Cy3 (n¼ 2
with bar show mean raw integrated density (RawIntDen) ± stand
CD3/AChE within a group was determined using an unpaired no
high patients were investigated with respect to bipolar (n ¼ 17
integrated density of co-localized pixels between CD64 and ACh
nonparametric Mann-Whitney test (****P  .0001).LPMF compared with low-fiber LPMF or not expressed
(Figure 12B, C, and F).
MF secrete different neurotrophic and axon-guidance
proteins as well as respective receptors. LPMF isolated
from high-fiber colonic tissue expressed growth/differenti-
ation factor (GDF) 15 and, to a lesser extent, GDF11
(Figure 12D and F). Within the family of axon-guidance
proteins, we found elevated expression of the receptors
neuropilin-1 (NRP1), UNC-5 homology B (UNC5B), and
ephrin type B-receptor 2 (EPHB2) binding semaphorin 3A
(SEMA3A), netrin, and ephrin-B family members, respec-
tively. In contrast, LPMF isolated from low-fiber segments
showed elevated expression of SEMA3A and SEMA7A
compared with LPMF originating from high-fiber segments
(Figure 12E and F).
These data suggested a possible involvement of nicotinic
and muscarinic AChRs in neuronal MF crosstalk. However,
data analysis was limited by low sample numbers and high
variance and thus needs further validation.Microbial Dysbiosis in Colonic Low-Fiber Tissues
From HSCR Patients
Lacking intestinal MF or ENS affects the composition of
intestinal microbiome. In a chemically induced colitis model
in mice, CX3CR1þ MF were crucial to maintain the intestinal
barrier function to prevent bacterial translocation.44 To
evaluate whether the presence of mucosal nerve fibers
correlated with altered passage of luminal bacteria through
the epithelium into the underlying tissue, we performed
bacteria-specific 16S rRNA fluorescence in situ hybridiza-
tion (FISH) analysis of low-fiber and high-fiber cryosections.
EUB338þ DAPIþ bacteria were detected in the mucosa of
both groups, but no significant difference was found
(Figure 13A and B). We analyzed the expression of the tight
junction proteins occludin and ZO-1 in isolated epithelial
cells from HSCR and control patients using qRT-PCR. The
coordinated interaction of those proteins is critical for the
assembly and maintenance of an effective epithelial barrier.
We showed that neither occludin nor ZO-1 was differentially
expressed in the diverse groups, suggesting no impact on
epithelial permeability between low-fiber and high-fiber
colonic tissue (Figure 13C). We then checked the composi-
tion of microbial communities by 16S rDNA sequencing in
cryosections of low-fiber, high-fiber, and ganglionic DCAChED fibers. (A) Immunofluorescence of epithelial region in
. Anti-AChE (red); anti-CD64 or anti-CD3 (green); DAPI (blue).
mm (original magnification, 20 images). (B) Confocal immu-
atient. Overlapping pixels (yellow, arrows) were visualized on a
1. (C) Quantification of pixel intensity of CD64þ MF and AChE
images from rectosigmoid colon regions of fiber-low (n ¼ 4 for
D3) patients as well as from colonic muscle regions of HSCR
ontrols were used: CD64-A488 or CD3-A488 with biotin þ
). Per patient (dot), 200–300 cells were analyzed. Scatter plots
ard error of the mean. Significance between CD64/AChE and
nparametric Mann-Whitney test. (D) CD64þ MF from 3 fiber-
0) or round/stellate (n ¼ 152) morphologic phenotype. Raw
E are shown. Significance was determined using an unpaired
Figure 10. CD64D LPMF asso-
ciate with neuronal AChED fi-
bers in HSCR colon. (A)
Immunofluorescence of epithelial/
mucosal region from aganglionic
and ganglionic colonic tissue from
HSCR and control patients using
CD64 (Alexa488, gray), AChE (Cy3,
red), and tubulin (Alexa647, green).
DAPI (blue) shows cell nuclei.
Scale bar: 50 mm. (B) Close-up
view of images from (A). Scale
bar: 10 mm. Encircled areas mark
the epithelial crypt/lumen. DC AG,
aganglionic descending colon; DC
G, ganglionic descending colon;
DC control, ganglionic descending
colon from control patients.
522 Keck et al Cellular and Molecular Gastroenterology and Hepatology Vol. 12, No. 2tissue from HSCR patients. Alpha diversity analysis showed
comparable levels of operational taxonomic units (OTUs) as
well as OTU richness (Shannon and Simpson index)
(Figure 14A). Beta diversity analysis revealed intersamplerelations (Figure 13D). On the phylum levels, Actinobacteria
seemed to be less prevalent in aganglionic tissue compared
with ganglionic tissue (Figure 14B). Within the bacterial
family compositions, Actinobacteria were, by trend, less
2021 Neuroimmune Association in HSCR Patients 523prevalent in low-fiber segments compared with ganglionic
DC, whereas other families were similarly expressed
(Figure 14C). The main representative species of theActinobacteria were several Bifidobacteria (B longum
(OTU1), B bifidum (OTU6), and B pseudocatenulatum
(OTU5)), with B longum showing the highest frequency in all
524 Keck et al Cellular and Molecular Gastroenterology and Hepatology Vol. 12, No. 2samples (Table 3). Differential bacterial family analysis be-
tween low-fiber and high-fiber colonic tissue revealed a
significant increase in Staphylococcaceae in low-fiber
colonic segments, whereas in high-fiber tissue, Enterobac-
teriaceae and Clostridiales Family_XI were up-regulated
(Figure 14D). Within the Staphylococcaceae family, S
aureus (OTU7) was the only detectable species within the
core microbiome (Table 3). The Clostridiales Family_XI was
represented by 4 genera, ie, Finegoldia (OTU825), Peptoni-
philus (OTU196), Anaerococcus (OTU543), and Ezakiella
(OTU27, OTU63). The main representative species of
Enterobacteriaceae family was Escherichia coli (OTU2),
which represented the second most frequent bacterial spe-
cies from the core microbiome (Table 3). These observa-
tions suggested a different composition of colon-associated
bacteria between low-fiber and high-fiber tissue including a
prevalence of Staphylococcaceae family in low-fiber seg-
ments lacking mucosal innervation. Because we only
analyzed age-matched samples, the data analysis was
limited by low sample numbers and high variance and thus
needs further validation.
HSCR Patients With Low-Fiber Phenotype
Showed a Higher Incidence of Postoperative
Enterocolitis
Next, we evaluated the impact of fiber phenotype on the
development of postoperative enterocolitis. One year after
pull-through surgery, 42 HSCR patients were followed up,
and postoperative enterocolitis manifestation was evaluated
from medical records. Enterocolitis was defined to fulfill at
least 3 of the following criteria: diarrhea (>3/day), vom-
iting, temperature >38.5C, antibiotics, hospitalization,
abdominal distention, and high inflammatory blood pa-
rameters (ie, leukocytes, C-reactive protein). Anthropo-
metric, clinical, environmental, maternal, and dietary
factors, collected from the parent questionnaire, were
analyzed for potential enterocolitis risk factors. A total of 9
of 42 patients developed postoperative enterocolitis within
1 year after surgery (Table 4). Development of enterocolitis
was significantly associated with cesarean delivery at birth
of the infant (P ¼ .012). Seven of the 9 patients exhibited a
low-fiber phenotype and only 2 a high-fiber phenotype,Figure 11. (See previous page). MF isolated from fiber-h
sequencing was performed on sorted viable colonic MF and b
between the different populations based on their first 2 princip
variance, were used. Fiber-low (green, n ¼ 4); fiber-high (blue, n ¼
Normalized sequence reads of selected macrophage-related gen
mean. (C) Global transcriptional changes between macrophage
tissue visualized by a volcano plot. Comparison of gene expres
package DESeq2. The Wald test was used to generate P values
and log2 fold change greater than 1 (red dots) and less than -1 (b
Heat map of differentially expressed genes. Each column repr
genes. Scatter plots with bar show means ± standard error of the
immunofluorescence in 5-mm colonic cryosections. Representa
(F) and fiber-high tissue (G) are shown. Scale bar: 30 mm. CD64
IL23 expression in macrophages evaluated in images from 4 fibe
per patient were analyzed for IL23 expression, and percentage o
Scatter plots with bar show means ± standard error of the mean
Mann-Whitney test.showing a higher incidence of low-fiber phenotype among
the children who developed enterocolitis (78% versus 22%,
P ¼ .634). To validate the observations, we analyzed a
retrospective HSCR patient cohort collected between 2003
and 2018 at the UKBB. A total of 29 HSCR patients were
included. We did not observe any significant patient bias in
terms of anthropometric or clinical factors between low-
fiber and high-fiber tissues (Table 6). Enterocolitis devel-
opment was recorded in 14 of 29 patients but showed no
correlation with anthropometric or clinical data (Table 4).
Strikingly, enterocolitis development correlated significantly
with the fiber phenotype, showing a higher incidence in
children with the low-fiber phenotype (86%, 12/14 chil-
dren) compared with the high-fiber phenotype (14%, 2/14).
These observations suggest that HSCR patients with low-
fiber phenotype might have a higher risk of developing
postoperative enterocolitis and that the fiber phenotype
could serve as a predictive marker for development of
prophylactic therapy.
Discussion
In recent years, multiple studies mainly using different
mouse disease models have demonstrated the reciprocal
relationship between the immune and nervous systems.
However, in humans the difficulty of studying the indi-
vidual effects of neurotransmitters leads to a lack of
studies providing evidence of neuroimmune crosstalk.
Here we suggested for the first time a correlation between
the presence of colonic mucosal AChEþ nerve fiber inner-
vation and a lower risk of developing enterocolitis in HSCR
patients lacking an intrinsic ENS. Aganglionic DC samples
showed elevated levels of inflammatory cytokines, which
decreased in samples with a functional ENS (ganglionic
DC) or in aganglionic high-fiber samples with mucosal
AChEþ nerve fibers. Similar to aganglionic DC samples, the
aganglionic low-fiber samples exhibited, by trend, elevated
IL17, IL1b, and IL6 cytokine levels. Th17 T cells in low-
fiber samples were significantly elevated compared with
high-fiber, aganglionic, and ganglionic DC samples. Strik-
ingly, Th17 frequencies were not elevated in aganglionic
DC samples, hypothesizing a different source of IL17 in
those samples or that there might be regionaligh colonic tissue express diminished IL23 levels. RNA
lood-derived M1 and M2 MF. (A) PCA plot shows similarity
al components. The top 500 genes, selected by highest row
5); muscle (red, n ¼ 3); M1 (black, n ¼ 3); M2 (gray, n ¼ 3). (B)
es. Scatter plots with bar show means ± standard error of the
s isolated from fiber-low colonic tissue and fiber-high colonic
sion between the groups of samples was performed with the
and log2 fold changes. Genes with an adjusted P value <.05
lue dots) were regarded as differentially expressed genes. (D)
esents 1 patient. (E) Normalized sequence reads of selected
mean. (F and G) IL23þ CD64þ MF (arrows) were assessed by
tive images of mucosal/epithelial region from fiber-low tissue
(A647, green); IL23p19-PE (red). (H) Quantitative analysis of
r-high and 4 fiber-low patients. Total of 900–4700 CD64þ cells
f IL23þ CD64þ cells (% of total macrophages) was calculated.








reads are shown. RNA
sequencing was performed on
sorted viable colonic MF
(CD45þ HLAþ CD64þ) from
mucosa of fiber-low (n ¼ 4) and
fiber-high (n ¼ 5) colonic tissue
as well as colonic muscle tis-
sue (n ¼ 3). Heat maps show
mean values of each group. (A)
Expression of nicotinic
(CHRNA) and muscarinic
(CHRM) ACh receptors. (B)
Expression of serotonergic
(HTR) and catecholaminergic
(ADRB) receptors. (C) Expres-
sion of receptors for neuro-




sion of neurotrophins (BMP
and GDF) and neurotrophin
receptors (NTRK2 binds brain-
derived neurotrophic factor
[BDNF] and neurotrophin [NT]-
4; GFRA2 and RET bind
GDNF and neurturin). (E)
Expression of axon-guidance
proteins and respective re-
ceptors. SEMA bind to plexins
or NRP1. UNC-5 represents
the receptor for netrin. Recep-
tor proteins ROBO1 and 3 bind
slit proteins. Neogenin (Neo)
receptor binds to repulsive
guidance protein (RGM). Eph-
rins bind to Eph receptors
EPHA and EPHB. (F) Normal-
ized sequence reads of
selected genes. Scatter plots
with bar show means ± stan-
dard error of the mean.
2021 Neuroimmune Association in HSCR Patients 525compartmentalization of Th17 T cells.45,46 Furthermore,
microbial colonization is crucial for Th17 T-cell differen-
tiation and maintenance, explaining reduced Th17 levels in
infants.47,48 The highest frequency of Treg cells wasdetected in cholinergic high-fiber segments. Interestingly,
Teratani et al49 recently reported that activation of vagal
parasympathetic nerves and enteric neurons stimulate
mAChRþ colonic APCs to differentiate and maintain
Figure 13. Microbial dysbiosis between fiber-low and fiber-high colonic tissue. (A and B) 16s rRNA FISH analysis was
performed on 5-mm cryosections of distal colon (rectum and sigmoid colon) of fiber-low (n ¼ 27) and fiber-high (n ¼ 8) HSCR
patients using a bacteria-specific probe (EUB338). (A) Representative images of fiber-low and fiber-high colonic tissue probed
with Cy3-labelled EUB338 and NON338 (negative control). Scale bar: 50 mm. (B) Frequencies of translocated bacteria
(16sRNAþ/DAPIþ) were determined using CellProfiler software and are shown as percentage of total DAPIþ cells. (C) qRT-PCR
analysis of isolated colonic epithelial cells from different aganglionic (AG) and ganglionic (G) colonic segments of HSCR and
control patients. Fiber-low (n ¼ 28); fiber-high (n ¼ 12); AG DC (n ¼ 10); G DC (n ¼ 10); control DC (n ¼ 5). Occludin was not
detectable in 2 fiber-low colonic tissue samples. (D) 16S rRNA analysis of colonic tissue from aganglionic (fiber-low, n ¼ 14;
fiber-high, n ¼ 11) and ganglionic (DC, n ¼ 4) segments of age-matched HSCR patients. Beta diversity 2-dimensional plot
shows patterns of intersample relations using detrended correspondence analysis (DCA).
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Figure 14. Colonic microbial dysbiosis in fiber-low colonic tissue from HSCR patients. (A–D) 16S rRNA analysis of colonic
tissue from aganglionic (fiber-low, n ¼ 14; fiber-high, n ¼ 11) and ganglionic (DC ganglionic, n ¼ 4) segments of age-matched
HSCR patients. (A) Alpha diversity analysis shows effects on observed OTUs and estimated OTU richness by Shannon and
Simpson indices. (B) Pie charts show microbial composition in each group on phylum level. (C) Normalized reads of bacterial
classes dedicated to respective phyla. Scatter blots with bar show mean values ± standard error of the mean. Significance was
determined using one-way analysis of variance multiple comparison analysis. (D) Differential bacterial family analysis of fiber-
low versus fiber-high groups. Asterisks mark significantly changed families with adjusted P value <.05 (***P ¼ 4.01  10-15;
**P ¼ 2.08  10-4; *P ¼ 0.022). Families are assigned to respective phyla by color code.
2021 Neuroimmune Association in HSCR Patients 527colitis-protective colonic Treg cells in an aldehyde
dehydrogenase–dependent manner.
Using confocal co-localization studies, we identified
elongated tissue-resident MF in close proximity to AchEþ
nerve fibers. Gabanyi et al33 described bipolar-shaped MMFwith a tissue-protective anti-inflammatory M2 phenotype
contrary to stellate-shaped LPMF. The elongated profile
allows MMF to interact and wrap around neighboring
neurites. At steady state, MMF regulate ENS functions and
therefore gut motility by providing bone morphogenetic
Table 3.Core Microbiome of 16S rDNA Sequencing of Colonic Tissue
OTU Sample Size Freq DomOTU Dom size DomID Min LoQ Med HiQ Max Taxonomy
1 36 748468 0.339 — — — 11 637 13721 36291 84291 k:Bacteria,p:Actinobacteria,c:Actinobacteria,o:Bifidobacteriales,
f:Bifidobacteriaceae,g:Bifidobacterium,s:Bifidobacterium_longum_E18
2 36 187671 0.0851 — — — 3 477 2619 7769 26234 k:Bacteria,p:Proteobacteria,c:Gammaproteobacteria,o:Enterobacteriales,
f:Enterobacteriaceae,g:Escherichia-Shigella,s:Escherichia_coli_
KOEGE_62_[175a]
4 36 48058 0.0218 — — — 5 33 219 847 21388 k:Bacteria,p:Proteobacteria,c:Gammaproteobacteria
10 36 48045 0.0218 — — — 1 150 423 2473 8624 k:Bacteria,p:Firmicutes,c:Bacilli,o:Lactobacillales,f:Enterococcaceae,
g:Enterococcus,s:Enterococcus_faecalis_EnGen0246
7 36 38523 0.0175 — — — 22 77 132 297 23544 k:Bacteria,p:Firmicutes,c:Bacilli,o:Bacillales,f:Staphylococcaceae,
g:Staphylococcus,s:Staphylococcus_aureus_M1256
21 36 29874 0.0135 — — — 18 94 178 530 9954 k:Bacteria,p:Actinobacteria,c:Actinobacteria,o:Corynebacteriales,
f:Corynebacteriaceae
42 36 21712 0.00984 — — — 28 116 316 668 2844 k:Bacteria,p:Proteobacteria,c:Alphaproteobacteria,o:Rhizobiales,
f:Rhizobiales_Incertae_Sedis,g:Phreatobacter
53 36 2804 0.00127 — — — 1 15 36 70 465 k:Bacteria,p:Proteobacteria,c:Betaproteobacteria,o:Burkholderiales,
f:Comamonadaceae,g:Delftia
43 36 2639 0.0012 — — — 3 12 29 68 501 k:Bacteria,p:Firmicutes,c:Bacilli,o:Bacillales,f:Bacillaceae,
g:Anaerobacillus
17 35 39122 0.0177 — — — 24 106 264 668 7842 k:Bacteria,p:Proteobacteria,c:Alphaproteobacteria,o:Rhizobiales,
f:Phyllobacteriaceae,g:Phyllobacterium
6 34 83714 0.0379 — — — 1 12 349 3129 26184 k:Bacteria,p:Actinobacteria,c:Actinobacteria,o:Bifidobacteriales,
f:Bifidobacteriaceae,g:Bifidobacterium,s:Bifidobacterium_
bifidum_ATCC_29521_¼_JCM_1255_¼_DSM_20456
19 34 7827 0.00355 — — — 1 8 36 132 1980 k:Bacteria,p:Firmicutes,c:Bacilli,o:Bacillales,f:Bacillaceae,g:Bacillus,
s:Bacillus_subtilis_subsp._subtilis
29 34 5688 0.00258 — — — 1 13 47 108 1491 k:Bacteria,p:Firmicutes,c:Bacilli,o:Bacillales,f:Listeriaceae,g:Listeria,
s:Listeria_monocytogenes
26 33 11261 0.0051 — — — 1 11 48 257 2658 k:Bacteria,p:Proteobacteria,c:Gammaproteobacteria,o:Pseudomonadales,
f:Pseudomonadaceae,g:Pseudomonas,s:Pseudomonas_aeruginosa_PACS2
35 33 5295 0.0024 — — — 1 8 41 129 1018 k:Bacteria,p:Firmicutes,c:Bacilli,o:Lactobacillales,f:Lactobacillaceae,
g:Lactobacillus,s:Lactobacillus_fermentum
65 33 5228 0.00237 — — — 2 18 56 136 1566 k:Bacteria,p:Proteobacteria,c:Gammaproteobacteria,o:Xanthomonadales,
f:Xanthomonadales_Incertae_Sedis,g:Acidibacter
12 32 20721 0.00939 — — — 1 1 5 291 5809 k:Bacteria,p:Bacteroidetes,c:Bacteroidia,o:Bacteroidales,f:Bacteroidaceae,
g:Bacteroides
5 31 40841 0.0185 — — — 1 3 21 100 20809 k:Bacteria,p:Actinobacteria,c:Actinobacteria,o:Bifidobacteriales,
f:Bifidobacteriaceae,g:Bifidobacterium,s:Bifidobacterium_pseudocatenulatum_
DSM_20438_¼_JCM_1200_¼_LMG_10505















OTU Sample Size Freq DomOTU Dom size DomID Min LoQ Med HiQ Max Taxonomy
831 30 21177 0.0096 — — — 1 3 34 303 13401 k:Bacteria,p:Firmicutes,c:Negativicutes,o:Selenomonadales,
f:Veillonellaceae,g:Veillonella
8 29 23263 0.0105 — — — 1 2 21 83 20960 k:Bacteria,p:Proteobacteria,c:Gammaproteobacteria,
o:Enterobacteriales,f:Enterobacteriaceae
812 28 12449 0.00564 — — — 1 7 29 68 5886 k:Bacteria,p:Firmicutes,c:Clostridia,o:Clostridiales,
f:Family_XI,g:Finegoldia
3 27 60864 0.0276 — — — 1 2 6 1975 26467 k:Bacteria,p:Bacteroidetes,c:Bacteroidia,o:Bacteroidales,
f:Bacteroidaceae,g:Bacteroides
75 27 4646 0.00211 — — — 2 10 36 112 2356 k:Bacteria,p:Proteobacteria,c:Alphaproteobacteria,o:Sphingomonadales,
f:Sphingomonadaceae,g:Sphingomonas
361 26 9680 0.00439 — — — 10 20 70 170 2600 k:Bacteria,p:Firmicutes,c:Bacilli,o:Lactobacillales,f:Enterococcaceae,
g:Enterococcus
69 26 3322 0.00151 — — — 1 5 15 56 2100 k:Bacteria,p:Proteobacteria,c:Betaproteobacteria,o:Burkholderiales,
f:Comamonadaceae,g:Acidovorax
44 25 12070 0.00547 — — — 1 3 23 496 4016 k:Bacteria,p:Actinobacteria,c:Actinobacteria,o:Bifidobacteriales,
f:Bifidobacteriaceae,g:Bifidobacterium
32 25 9946 0.00451 — — — 1 2 10 98 4090 k:Bacteria,p:Firmicutes,c:Bacilli,o:Lactobacillales,f:Enterococcaceae,
g:Enterococcus,s:Enterococcus_pallens_ATCC_BAA-351
9 24 93012 0.0422 — — — 2 6 88 4570 36070 k:Bacteria,p:Actinobacteria,c:Coriobacteriia,o:Coriobacteriales,
f:Coriobacteriaceae,g:Collinsella,s:Collinsella_aerofaciens
196 24 6264 0.00284 — — — 1 6 12 172 2096 k:Bacteria,p:Firmicutes,c:Clostridia,o:Clostridiales,f:Family_XI,
g:Peptoniphilus
541 22 40265 0.0183 — — — 1 2 9 318 16032 k:Bacteria,p:Firmicutes,c:Clostridia,o:Clostridiales,f:Family_XI,
g:Anaerococcus
22 22 21390 0.0097 — — — 1 8 157 507 13925 k:Bacteria,p:Actinobacteria,c:Actinobacteria,o:Actinomycetales,
f:Actinomycetaceae,g:Varibaculum
13 21 40558 0.0184 — — — 1 7 55 1183 27312 k:Bacteria,p:Proteobacteria,c:Betaproteobacteria,o:Burkholderiales,
f:Alcaligenaceae,g:Sutterella
14 21 19704 0.00893 — — — 1 3 6 30 11191 k:Bacteria,p:Bacteroidetes,c:Bacteroidia,o:Bacteroidales,
f:Bacteroidaceae,g:Bacteroides
24 21 5238 0.00237 — — — 1 6 22 320 1720 k:Bacteria,p:Firmicutes,c:Clostridia,o:Clostridiales,f:Clostridiaceae_1,
g:Clostridium_sensu_stricto_1,s:Clostridium_paraputrificum
41 20 13038 0.00591 — — — 2 4 28 1340 3766 k:Bacteria,p:Firmicutes,c:Clostridia,o:Clostridiales,f:Ruminococcaceae,
g:Flavonifractor
20 19 15971 0.00724 — — — 1 2 7 202 9414 k:Bacteria,p:Bacteroidetes,c:Bacteroidia,o:Bacteroidales,f:Bacteroidaceae,
g:Bacteroides
23 19 8516 0.00386 — — — 1 1 3 78 5426 k:Bacteria,p:Bacteroidetes,c:Bacteroidia,o:Bacteroidales,f:Bacteroidaceae,
g:Bacteroides
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16 17 47772 0.0217 — — — 2 2 6 26 23950 k:Bacteria,p:Actinobacteria,c:Actinobacteria,o:Actinomycetales,
f:Actinomycetaceae,g:Actinomyces,s:Actinomyces_turicensis_
ACS-279-V-Col4
55 17 2996 0.00136 — — — 1 1 2 31 1278 k:Bacteria,p:Firmicutes,c:Bacilli,o:Lactobacillales,f:Lactobacillaceae,
g:Lactobacillus,s:Lactobacillus_casei_5b
11 16 78452 0.0356 — — — 2 8 24 164 77484 k:Bacteria,p:Actinobacteria,c:Actinobacteria,o:Actinomycetales,
f:Actinomycetaceae,g:Actinomyces,s:Actinomyces_europaeus_
ACS-120-V-Col10b
34 16 15444 0.007 — — — 2 6 88 1078 10006 k:Bacteria,p:Actinobacteria,c:Actinobacteria,o:Actinomycetales,
f:Actinomycetaceae,g:Actinomyces
18 16 13394 0.00607 — — — 1 1 5 34 13099 k:Bacteria,p:Bacteroidetes,c:Bacteroidia,o:Bacteroidales,
f:Bacteroidaceae,g:Bacteroides
38 16 4860 0.0022 — — — 1 2 8 33 4592 k:Bacteria,p:Cyanobacteria,c:Chloroplast
30 15 17280 0.00783 — — — 2 2 18 334 7174 k:Bacteria,p:Bacteroidetes,c:Bacteroidia,o:Bacteroidales,f:Rikenellaceae,
g:Alistipes,s:Alistipes_sp._AL-1
31 15 5940 0.00269 — — — 1 1 25 159 3221 k:Bacteria,p:Firmicutes,c:Clostridia,o:Clostridiales,f:Lachnospiraceae,
g:Lachnoclostridium
56 15 2690 0.00122 — — — 1 2 46 150 1418 k:Bacteria,p:Firmicutes,c:Clostridia,o:Clostridiales,f:Lachnospiraceae,
g:Blautia
869 14 18179 0.00824 — — — 1 2 45 1432 11357 k:Bacteria,p:Firmicutes,c:Negativicutes,o:Selenomonadales,f:Veillonellaceae,
g:Veillonella,s:Veillonella_sp._FFA-2014
25 13 47392 0.0215 — — — 4 4 12 384 38992 k:Bacteria,p:Actinobacteria,c:Coriobacteriia,o:Coriobacteriales,
f:Coriobacteriaceae,g:Atopobium,s:Atopobium_minutum_10063974
36 13 13810 0.00626 —- — — 2 4 42 118 5966 k:Bacteria,p:Bacteroidetes,c:Bacteroidia,o:Bacteroidales,
f:Porphyromonadaceae,g:Parabacteroides
51 13 4162 0.00189 — — — 1 5 48 308 2476 k:Bacteria,p:Proteobacteria,c:Deltaproteobacteria,o:Desulfovibrionales,
f:Desulfovibrionaceae,g:Bilophila,s:Bilophila_wadsworthia_3_1_6
47 13 3704 0.00168 — — — 1 2 3 162 3021 k:Bacteria,p:Firmicutes,c:Clostridia,o:Clostridiales,f:Lachnospiraceae,g:Blautia
49 13 3246 0.00147 — — — 1 1 12 94 2146 k:Bacteria,p:Firmicutes,c:Clostridia,o:Clostridiales,f:Lachnospiraceae,
g:Fusicatenibacter
39 13 2864 0.0013 — — — 1 11 53 372 1164 k:Bacteria,p:Firmicutes,c:Clostridia,o:Clostridiales,f:Clostridiaceae_1,
g:Clostridium_sensu_stricto_1,s:Clostridium_perfringens_C_str._JGS1495
54 13 2692 0.00122 — — — 1 2 95 135 952 k:Bacteria,p:Bacteroidetes,c:Bacteroidia,o:Bacteroidales,f:Bacteroidaceae,
g:Bacteroides
15 12 31270 0.0142 — — — 3 4 16 59 30279 k:Bacteria,p:Verrucomicrobia,c:Verrucomicrobiae,o:Verrucomicrobiales,
f:Verrucomicrobiaceae,g:Akkermansia
37 11 5809 0.00263 — — — 1 1 2 897 3587 k:Bacteria,p:Firmicutes,c:Bacilli,o:Lactobacillales,f:Lactobacillaceae,
g:Lactobacillus,s:Lactobacillus_rhamnosus_DSM_20021_¼_JCM_
1136_¼_NBRC_3425
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48 10 6673 0.00302 — — — 1 3 5 207 3953 k:Bacteria,p:Actinobacteria,c:Actinobacteria,o:Actinomycetales,
f:Actinomycetaceae,g:Actinobaculum,s:Actinobaculum_massiliae_
ACS-171-V-Col2
68 10 3685 0.00167 — — — 1 1 215 761 1500 k:Bacteria,p:Firmicutes,c:Clostridia,o:Clostridiales,f:Ruminococcaceae,
g:Faecalibacterium
925 9 8666 0.00393 — — — 1 2 10 95 5933 k:Bacteria,p:Firmicutes,c:Clostridia,o:Clostridiales,f:Ruminococcaceae,
g:Anaerotruncus,s:Clostridiales_bacterium_VE202-13
40 9 3327 0.00151 — — — 1 1 2 3 3079 k:Bacteria,p:Proteobacteria,c:Betaproteobacteria,o:Burkholderiales,
f:Alcaligenaceae,g:Sutterella
62 9 2509 0.00114 — — — 1 1 1 37 1398 k:Bacteria,p:Firmicutes,c:Clostridia,o:Clostridiales,f:Lachnospiraceae,
g:Roseburia
52 8 7846 0.00356 — — — 2 38 124 1712 5452 k:Bacteria,p:Firmicutes,c:Clostridia,o:Clostridiales,f:Ruminococcaceae,
g:Faecalibacterium
33 8 5962 0.0027 — — — 1 4 70 208 5591 k:Bacteria,p:Firmicutes,c:Clostridia,o:Clostridiales,f:Lachnospiraceae,
g:Blautia
45 8 3781 0.00171 — — — 1 1 6 445 2946 k:Bacteria,p:Firmicutes,c:Clostridia,o:Clostridiales,f:Lachnospiraceae,
g:Lachnoclostridium
60 8 3273 0.00148 — — — 1 1 132 1346 1581 k:Bacteria,p:Proteobacteria,c:Betaproteobacteria,o:Neisseriales,
f:Neisseriaceae,g:Eikenella
27 7 14998 0.0068 — — — 3 3 17 481 14392 k:Bacteria,p:Firmicutes,c:Clostridia,o:Clostridiales,f:Family_XI,g:Ezakiella
57 7 6330 0.00287 — — — 2 4 6 88 6174 k:Bacteria,p:Bacteroidetes,c:Bacteroidia,o:Bacteroidales,f:Prevotellaceae,
g:Prevotella
70 7 3574 0.00162 — — — 1 3 35 275 3217 k:Bacteria,p:Firmicutes,c:Clostridia,o:Clostridiales,f:Ruminococcaceae,
g:Subdoligranulum
101 7 2778 0.00126 — — — 2 2 18 958 1250 k:Bacteria,p:Firmicutes,c:Clostridia,o:Clostridiales,f:Ruminococcaceae,
g:Faecalibacterium
77 6 3612 0.00164 — — — 2 30 46 1616 1884 k:Bacteria,p:Firmicutes,c:Clostridia,o:Clostridiales,f:Ruminococcaceae,
g:Ruminococcaceae_UCG-005
46 6 2824 0.00128 — — — 1 1 74 172 2574 k:Bacteria,p:Bacteroidetes,c:Bacteroidia,o:Bacteroidales,
f:Porphyromonadaceae,g:Parabacteroides
63 5 4055 0.00184 — — — 1 3 300 387 3364 k:Bacteria,p:Firmicutes,c:Clostridia,o:Clostridiales,f:Family_XI,g:Ezakiella
100 5 2420 0.0011 — — — 8 38 136 156 2082 k:Bacteria,p:Actinobacteria,c:Coriobacteriia,o:Coriobacteriales,
f:Coriobacteriaceae,g:Slackia











Table 4.Risk Factors for Postoperative Enterocolitis Development
Prospective HSCR patient cohort
No. patients positive for risk factor/
available patient data (percentage) Enterocolitis
Anthropometric data and potential risk
factors (no. of available patient data)
Total patients
followed up, n ¼ 42 Yes, n ¼ 9 No, n ¼ 33 P value
Age at operation, mo (42) 5 [1–127] 3 [1–127] 5 [2–70] .211
Sex, male (42) 34/42 (81%) 7 (78%) 27 (81%) .784
Preterm birth (38) 3/38 (7%) 2 (22%) 1 (3%) .068
Operative procedure transanal (42) 37/42 (88%) 8 (89%) 29 (88%) .934
Length of aganglionosis (42) 2 [1–5] 1 [1–5] 2 [1–5] .061
Pets (37) 12/37 (32%) 1 (11%) 11 (39%) .116
Patient living in rural area (40) 20/40 (50%) 3 (33%) 17 (55%) .256
Antibiotic treatment (38) 5/38 (13%) 2 (22%) 3 (10%) .357
Siblings (39) 30/39 (77%) 8 (89%) 22 (73%) .331
Breastfed at operation (39) 36/39 (92%) 9 (100%) 27 (90%) .323
Maternal age at delivery, y (35) 28 [21–43] 27 [23–39] 29 [21–43] .788
Parental smoking (38) 9/38 (21%) 4 (44%) 5 (17%) .094
Cesarean section (38) 14/38 (37%) 6 (75%) 8 (27%) .012
Maternal allergy (38) 10/38 (26%) 1 (11%) 9 (31%) .236
Fiber-low (42) 30/42 (71%) 7 (78%) 23 (70%) .634
Retrospective HSCR patient cohort (no.
of available patient data) Total, n ¼ 29 Yes, n ¼ 14 No, n ¼ 15 P value
Age at operation (mo) (29) 5 [1–171] 4 [1–48] 9 [1–171] .229
Sex, male (29) 25/29 (86%) 11 (79%) 14 (93%) .249
Preterm birth (29) 2/29 (7%) 1 (7%) 1 (7%) .960
Antibiotic treatment (29) 21/29 (72%) 10 (7%) 11 (73%) .909
Cesarean section (29) 12/29 (41%) 7 (50%) 5 (33%) .124
Fiber-low (29) 15/29 (52%) 12 (86%) 3 (20%) <.001
NOTE. Values are median [range] or number of patients (percentage %).
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Tamoxifen-induced deletion of CX3CR1þ tissue-resident
MF leads to loss of enteric neurons.50 Interestingly, MMF
develop independently of the ENS.51 Neuroimmune modu-
lation seems to involve different neuronal receptors. Upon
Salmonella typhimurium infection, MMF interact with sym-
pathetic adrenergic neurons via b2 adrenergic receptors to
induce a tissue- and neuron-protective gene expression
program.33 In a model of POI that is characterized by a
surgery-induced inflammatory response of MMF and
impaired motility, VN stimulation or pharmacologic trig-
gering of cholinergic enteric neurons prevented MF acti-
vation and reduced POI in an a7nAChR-dependent manner
in both mice and humans.39 In a murine model of food
allergy, VN stimulation ameliorated disease severity inde-
pendently of a7nAChR.52 Uptake of food antigens by anti-
inflammatory CX3CR1þ MF and subsequent induction of
food-specific Tregs effectively prevent allergic reactions.29
VN stimulation increases phagocytic activity in CX3CR1þ
MF independently of a7nAChR, but phagocytic activity re-
mains dependent on a4b2nAChR.53 Using a murine hel-
minth infection model, it has been demonstrated that the
neuropeptide neuromedin U activates ILC2, thus increasing
the protective immune response and parasitic clear-
ance.40,41 In contrast, signals from sympathetic adrenergic
neurons lead to attenuated ILC2 effector function and pre-
vent chronic pathologic type 2 inflammation via activationof ILC2-specific b2 adrenergic receptors.54 In the current
study we performed transcriptional analysis of sorted MF
isolated from high-fiber and low-fiber colonic tissue.
Although the analysis did not provide a functional rela-
tionship between MF and cholinergic fibers, we found a
tendency of elevated nicotinic and muscarinic receptors
expressed by MF isolated from high-fiber compared with
low-fiber tissue. Colonic MF represent the main APC subset
in the colon, and their phenotype and secreted cytokines
influence CD4 T-helper cell differentiation.28–30,55 However,
a functional mechanism between the different patient-
derived colonic macrophages and the observed T-helper
cell subsets still has to be provided. The results obtained
from experiments using blood-derived M1 and M2 MF
cannot be extrapolated to the colonic population and only
exemplify the impact of MF phenotype on T-helper cell
differentiation.
In our study, IL23, a cytokine promoting the mainte-
nance of Th17 cells, is significantly increased in LPMF iso-
lated from low-fiber tissue compared with LPMF isolated
from innervated high-fiber tissue. Genome-wide studies
identified genes, including the gene for IL23 receptor,
associated with a susceptibility to inflammatory bowel dis-
ease.56 IL23 is produced by dendritic cells and MF in
response to extracellular bacteria and fungi recognized by
special innate pattern-recognition receptors: the toll-like
receptor 2 and nucleotide oligomerization domain
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1 F 22 2 L-HSCR low 3, 6 4,5,6
2 F 7 6 TCA low 1,3,5,6 2,4
3 M 2 1 S-HSCR high 1 3,5,6
4 M 171 1 TCA low no no
5 M 9.5 1 TCA high 1 6
6 M 2 1 L-HSCR low 3, 6 3,4,5,6
7 M 3.5 1 S-HSCR high 1, 2 2
8 M 1 1 S-HSCR high no no
9 M 10.7 1 S-HSCR high 1,6 5
10 F 25 2 S-HSCR high no no
11 M 48 1 S-HSCR high 1,3,6 1,2,3,4,5
12 M 52 2 S-HSCR high 2 1,5,6
13 M 1 1 L-HSCR low 1,2,3 2,4,5
14 M 28.5 1 S-HSCR high 2 6
15 M 4 7 TCA low 1,3,4,5,6 4,5,6
16 F 2.8 1 TCA low 3 4,5
17 M 3.7 1 S-HSCR low 3 no
18 M 8 6 S-HSCR low 1,3 1,5
19 M 5 1 L-HSCR high 2 no
20 M 7 1 S-HSCR high 3 4
21 M 9 1 TCA low 3,5 3,4,5
22 M 60 2 S-HSCR high no no
23 M 67 1 L-HSCR high 2,6 6
25 M 1.5 1 S-HSCR low 3 1,2,3,4,5
27 M 3.5 1 S-HSCR low no no
30 M 3 1 L-HSCR low 1,3 3,4,5,6
31 M 4.3 1 S-HSCR low 3,6 5
32 M 1.5 1 S-HSCR low no no
33 M 2 1 L-HSCR high 5 no
Length of aganglionosis: TCA (total colonic aganglionosis); L-HSCR (long-segmented HSCR); S-HSCR (short-segmented
HSCR).
Table 6.Characteristics of HSCR Retrospective Patient Cohort
Anthropometric data and
potential risk factors
No. patients positive for risk factor/
total patients (%) Fiber-low (n ¼ 15) Fiber-high (n ¼ 14) P value
Age at operation, mo 5 [1–171] 3 [1–127] 9.5 [1–67] .063
Sex, male 25/29 (86) 12 (80) 13 (93) .316
Preterm birth 2/29 (7) 1 (7) 1 (7) .960
Antibiotic treatment 21/29 (72) 12 (80) 9 (64) .550
Caesarean section 12/29 (41) 6 (40) 6 (43) .876
NOTE. Values are median [range] or number (percentage).
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534 Keck et al Cellular and Molecular Gastroenterology and Hepatology Vol. 12, No. 2containing protein 2. Under inflammatory conditions,
monocyte-derived CCR2þ CX3CR1þ MF infiltrate the gut
mucosa and prime Th17 cell responses. At steady state,
CX3CR1þ MF are indispensable for epithelial integrity,
control of bacterial translocation, and development of oral
and commensal tolerance by secreting anti-inflammatory
cytokines and maintaining Treg.29
In our study, we found higher tissue expression of
CX3CR1 than CCR2 in high-fiber colonic segments of HSCR
patients and described 2 MF populations based on CD14
expression and shape. CD14þ bipolar MF were found in
close proximity to nerve fibers in both muscularis and
lamina propria, expressing low levels of CCR7, suggesting a
tissue-resident phenotype. CD14low stellate-shaped MF
were present in non-innervated LP from low-fiber tissue,
expressing high levels of CCR7, thus indicating a migratory
population. On the basis of their transcriptional profile,
LPMF isolated from both low-fiber and high-fiber colonic
tissues exhibited a gut-imprinted M2 phenotype (CX3CR1,
AREG, AhR, CSF1R, CD200R, CD209, TGFb2, and IL10), but
they differed in Th17 cytokines (IL23 and IL6) and Th17
chemokines (CCL20). Consequently, the presence of
mucosal AChEþ nerve fibers seemed to be associated with
reduced type-17 immune responses. In a murine model of
psoriasis, sensory nociceptive neurons augment dermal
dendritic cell-mediated IL23 production.42 The neurons
directly sense disease-inducing Candida albicans and release
the neuropeptide calcitonin gene-related peptide, which
increases IL23 production.43 Surprisingly, another study
uncovered an immunosuppressive effect of nociceptive fi-
bers during S aureus infection, indicating a role for the
properties of the underlying pathogen or target immune cell
on neuronal-induced immune modulation.57
Neurotrophic factors and their respective receptors are
crucial for ENS development and function. In fact, the un-
derlying genetic defects in HSCR patients involve signaling
pathways controlling migration and development of the
ENS, including the 2 major HSCR genes, rearranged during
transfection (Ret) and endothelin receptor type B (EndrB).
In a study using Ret-deficient mice, the authors demon-
strated that microbiota-induced glial cell–derived neuro-
trophic factors induce IL22 in Ret-expressing ILC3,
therefore maintaining intestinal homeostasis.58 Ret expres-
sion was not detected in colonic MF populations, and we
did not detect any changes in ILC3 frequencies between
low-fiber and high-fiber colonic segments. Here we used
RNA-seq transcriptional analysis of sorted colonic MF to
identify factors and receptors possibly involved in neuro-
immune interactions. However, the RNA-seq data were
highly variable within the groups, and a proof of a functional
relationship is missing. Further studies are needed to fully
uncover mechanisms involved in neuron-MF interactions.
Besides the potential contribution of nicotinic and musca-
rinic receptors, we considered the contribution of neuro-
trophic factors, axon-guidance proteins, and their respective
receptors in possible neuron-MF interactions. GDF15 has
been reported to suppress inflammatory responses in a
murine model of endotoxin-induced sepsis and prevent
maturation of inflammatory dendritic cells in a hearttransplantation model.59 Using an imiquimod- or IL23-
induced mouse model of psoriasis-like skin inflammation,
GDF11 administration attenuated the severity of skin
inflammation via suppression of the nuclear factor kappa B
signaling pathway.60 Recently, NRP-1 was identified in
adipose-tissue MF protecting from metabolic syndrome by
favoring fatty acid uptake and b-oxidation away from pro-
inflammatory M1 polarization and glycolysis.61 In addition,
in a model of a neurodevelopmental disorder, brown
adipose-tissue MF control sympathetic tissue innervation
critical for thermogenesis via the plexin-semaphorin
pathway.35
The microbial composition of feces from HSCR patients
with enterocolitis is shifted toward opportunistic pathogens
such as Candida albicans and Clostridium difficile.1,62 In our
study, none of the patients were diagnosed with enteroco-
litis at the time of the pull-through surgery. However, higher
baseline frequencies of Th17 cells and IL23 might promote
C difficile infection, as was recently postulated.63 Compared
with high-fiber colonic tissue, low-fiber tissue was associ-
ated with higher levels of S aureus previously reported to be
associated with an increased Th17 response.64 In contrast,
Clostridiales Family_XI was up-regulated more than 2 log2
fold in high-fiber tissue compared with low-fiber tissue,
which was reported to be associated with a decreased risk
of C difficile infection and necrotizing enterocolitis in pre-
term children.65 In our study, differential bacterial analysis
was limited because of the small sample size and high
variability within the groups. The fact that we analyzed
bacterial communities in colonic tissue rather than feces
further limited the data analysis.
Overall, 9 of 42 patients developed HSCR-associated
enterocolitis in the year after surgery. Interestingly, devel-
opment of enterocolitis was significantly associated with
cesarean delivery at birth of the infant in the prospective
HSCR patient cohort. Microbial composition in children
delivered by cesarean section is known to be associated
with skin commensals such as Staphylococcus, whereas the
microbiome in children delivered by vaginal birth mode is
characterized by vaginal bacteria, eg, Bifidobacteria and
Lactobacillus.66 However, because cesarean section was not
a significant risk factor in the retrospective patient cohort,
its role in enterocolitis development needs to be further
examined. Analyzing the correlation of fiber phenotype with
enterocolitis development in the year after surgery showed
a higher incidence for low-fiber phenotype (78%) than high-
fiber phenotype (22%) in patients developing enterocolitis.
The result was validated in a retrospectively analyzed HSCR
patient cohort and showed a significant incidence of 86%
(low-fiber phenotype) versus 14% (high-fiber phenotype)
developing enterocolitis. In the prospective cohort, the low-
fiber phenotype was not significantly associated with the
outcome enterocolitis, most likely because of the small
number of patients who experience this outcome as well as
an unequal distribution of the low-fiber/high-fiber pheno-
type. When pooling the prospective and the retrospective
dataset together, n ¼ 23 had enterocolitis, and n ¼ 48 did
not have this outcome. Patients with the low-fiber pheno-
type experienced significantly more enterocolitis than those
2021 Neuroimmune Association in HSCR Patients 535with the high-fiber phenotype (n ¼ 19 versus n ¼ 4, P ¼
.020). This finding indicates an association between a low-
fiber phenotype and the development of enterocolitis in
patients with Hirschsprung disease. Interestingly, in HSCR
mouse models using EndrB-deficient mice, no mucosal
nerve fibers were detected, and the mice exhibited microbial
dysbiosis leading to enterocolitis.67
The absence of mucosal AChEþ fibers could therefore
serve as a predictive marker for enterocolitis and improve
personalized patient management. With the current post-
operative therapeutic management, clinicians react to in-
flammatory bowel situations only at the time point of
enterocolitis onset. Using the fiber phenotype as a prog-
nostic marker for the risk of enterocolitis, clinicians could
directly react after pull-through surgery to prevent post-
operative enterocolitis. Possible therapies include high-
volume enemas, antibiotic interval treatment, prebiotic
and probiotic therapy, as well as dietary adaptations. In
addition, interventional surgical corrections may be
considered. For instance, it is still unclear how the neuronal
phenotype of a resected colon segment might predispose for
enterocolitis development. It has been reported that colonic
inflammatory Th17 cells migrate to neighboring mesenteric
lymph nodes, triggering enterocolitis development. Because
the mesentery is generally not removed during surgery, this
could explain why patients may develop enterocolitis after
removal of affected aganglionic colon segments. Using the
fiber phenotype as a prognostic enterocolitis marker would
enable possible resection of the neighboring mesentery
lymph nodes/tissue as a strategy to prevent enterocolitis.
Furthermore, immunotherapies targeting IL17 or IL23
rather than TNF-a could open new therapeutic treatment
options.
The study is limited by its correlative nature requiring
further investigations and validations. The fiber phenotype
we investigated reflects the situation at the time point of
pull-through surgery. It is unclear which factors drive the
different innervation pattern between low-fiber and high-
fiber tissue. There could be certain dietary or microbial
triggers inducing mucosal fiber sprouting into the LP close
to epithelial crypts in high-fiber tissue. A recent publication
suggested a direct effect of the microbiome on gut extrinsic
sympathetic neurons mediated by distal intestine-projecting
afferent vagal neurons.68 However, when analyzing data
from the parent questionnaire, no significant difference in
diet or domestic environment known to influence the mi-
crobial composition (eg, living area, siblings, pets) could be
determined. On the other hand, one could assume that the
low-fiber phenotype is a result of fiber loss due to epithelial
barrier disruption resulting in tissue and neuro-
inflammation. However, we did not detect lower expression
of epithelial tight junction proteins in low-fiber tissue, and
we did not observe a higher bacterial translocation into low-
fiber compared with high-fiber tissue. Although the origin of
the fiber phenotype stays elusive, we suggest that the
presence of neuronal cholinergic innervation in the colon
might help to maintain a tolerogenic anti-inflammatory
immune cell status to prevent excessive immune re-
sponses and tissue pathology. The involved cell types andmechanisms as well as microbial contributions remain to be
further investigated.
Using an HSCR patient cohort lacking the ENS, we
showed that mucosal AChEþ nerve fibers associate with MF
and correlate with reduced type-17 immune response,
possibly mediated by reduced MF-dependent IL23 expres-
sion. HSCR patients lacking mucosal nerve fibers in the
distal colon had a higher risk of developing postoperative
enterocolitis. The mucosal fiber phenotype could serve as a
new prognostic marker for HSCR-associated enterocolitis
risk, offering personalized patient care and future thera-
peutic options.Materials and Methods
Patients and Human Specimens
A total of 44 children (median age, 5 months) with HSCR
as well as miscellaneous intestinal diseases (non-HSCR,
control group) were enrolled in a prospective multicenter
study conducted in Switzerland and Germany. The study
was approved by the Ethics Committees of Northwest/
Central Switzerland (EKNZ 2015-049) and the Medical
Faculty Heidelberg (S-388/2015). The study was registered
at www.clinicaltrials.gov (accessing number NCT03617640)
and was performed according to the Declaration of Helsinki.
After obtaining consent, fresh unfixed colonic tissue was
collected in the operating room. For histologic analysis, a
longitudinal strip of resected colonic tissue was immediately
snap-frozen. Tissue for RNA analysis was stored in RNAlater
(Qiagen, Hilden, Germany) or immediately frozen on dry ice.
Tissue for FACS analysis was kept on ice in Hanks’ balanced
salt solution supplemented with 100 U penicillin, 0.1 mg/
mL streptomycin, 0.25 mg/mL amphotericin B, and 40 mg/
mL gentamycin and was processed in less than 24 hours.
The HSCR group included patients with short-segment (n ¼
31), long-segment (n ¼ 6), and total (n ¼ 7) colonic agan-
glionosis. Surgery was performed according to the Swenson
or Soave procedures (Table 1). The length of aganglionosis
was determined intraoperatively by mapping biopsies and
postoperatively in the resected tissue via enzyme-
histochemical staining. Tissue staining and assessment
were performed by the pathology units of the respective
clinics (Table 7). Ganglionic tissue was characterized by the
presence of intrinsic nerve cell bodies. The presence of
intrinsic nerve cell bodies (ganglia) was detected by several
enzyme histochemical stainings: lactic dehydrogenase, suc-
cinic dehydrogenase, NOS, nicotinamide adenine dinucleo-
tide phosphate, and immunohistochemical calretinin
staining. Aganglionic tissue was characterized by the lack of
intrinsic cell bodies and presence of extrinsic nerve fibers in
the distal colon.
Extrinsic nerve fibers were detected by enzyme histo-
chemical AChE staining. Study group characteristics (clinical
and nonclinical variables) were evaluated via a parent
questionnaire. Postoperative symptoms (constipation, in-
continence, enterocolitis, and pain) as well as postoperative
treatments (laxative, enema, Botox, antibiotics, colonic irri-
gation, and prebiotics/probiotics) were evaluated from
medical records 1 year after surgery.
Table 7.Enzyme Histochemistry Performed at the Different









LDH, NOS, SDH AChE
Zürich LDH AChE
Bern LDH, NOS AChE
St Gallen SDH AChE
Lausanne LDH AChE
Heidelberg Calretinin AChE
Düsseldorf NADPH, LDH AChE
LDH, lactic dehydrogenase; NADPH, nicotinamide adenine
dinucleotide; SDH, succinic dehydrogenase.
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following criteria: diarrhea (>3/day), vomiting, tempera-
ture >38.5C, antibiotics, hospitalization, abdominal
distention, and high inflammatory blood parameters (ie,
leukocytes, C-reactive protein). For the retrospective cohort
analysis, we included HSCR patients diagnosed and treated
at the University Children’s Hospital Basel between 2003
and 2018. Patients were identified using International
Classification of Diseases, 10th version diagnosis Q43.1.
Swiss roll cryosections (5 mm) from resected distal agan-
glionic colon were provided by the Department of Pathol-
ogy, University Hospital Basel, Basel, Switzerland. Fiber
scoring was performed using beta III tubulin immunohis-
tochemistry and evaluated in a double-blind fashion by 3
individuals. Demographic and clinical data were extracted
from medical records. Enterocolitis was defined on the basis
of the same criteria as in the prospective cohort study. The
study was approved by the Ethics Committee of North-West
Switzerland (EKNZ 2019-01406).
Immunohistochemistry and Nerve Fiber Scoring
Longitudinal colonic strips were washed in ice-cold
phosphate buffered saline (PBS) and embedded as a Swiss
roll in Tissue-Tek O.C.T. Compound (Sakura, Osaka, Japan).
Cholinergic nerve fibers were visualized in 5-mm cry-
osections using mouse immunoglobulin (Ig)G2b anti-human
AChE (Abcam, Cambridge, UK) or mouse IgG2a anti-human
beta III tubulin antibody together with an anti-mouse HRP-
AEC staining kit (R&D Systems, Minneapolis, MN) according
to instruction manuals. Slides were automatically scanned
using an Olympus (Tokyo, Japan) BX63 motorized bright-
field microscope using a 10 objective. Presence of extrinsic
nerve fibers in mucosal regions of the distal aganglionic
colon was evaluated semiquantitatively in a double-blind
investigation by 4 individuals. Mucosal regions were clas-
sified into 4 different fiber innervation grades according to
absent, low, intermediate, and high innervation density
(Figure 8A).25 Innervation grades 1 and 2 were grouped into
low-fiber and 3 and 4 were grouped into high-fiber HSCRpatients. For the quantitative measure of the AChEþ nerve
fibers in the mucosal regions, images were analyzed using
brightfield microscope and CellSens Dimension 2.2 Software
(Olympus). On average, 6 cropped regions of interest con-
taining 10 epithelial crypts from distal colon, resulting in 60
crypts per patients, were analyzed. In total, 12 patients (3
patients per innervation grade) were chosen according to
the visual scoring. A defined manual threshold was applied
on each cropped image, and object counts were obtained by
the Olympus CellSens dimension software (Figure 2).
Isolation of Mononuclear Cells From Colonic
Tissue
Colonic specimens were separated into rectum, sigmoid
colon, descending colon, transverse colon, and ascending
colon (distal to proximal) according to the length of the
resected colon.69 Excess fat was removed, and muscle layers
were stripped from the mucosa. Mucosa and muscle tissue
were minced and digested separately with collagenase D (1
mg/mL) and DNase I (4 mg/mL; both Roche Diagnostics,
Basel, Switzerland) in complete medium (RPMI-1640 sup-
plemented with 10% fetal calf serum, 200 U penicillin, 0.2
mg/mL streptomycin, 0.5 mg/mL amphotericin B, 80 mg/mL
gentamycin, and 10 mmol/L Hepes) at 37C for 1 hour
under vigorous shaking. Digestion suspension was filtered
through a 100-mm cell strainer, and cells were washed in
complete medium. Suspension cells were resuspended in
20% Percoll (Pharmacia, Piscataway, NJ) (3 mL) and un-
derlaid with 40% Percoll and 70% Percoll (3 mL of each).
Mononuclear cells and epithelial cells were purified from
the 40%/70% and the 20%/40% Percoll interface, respec-
tively. Mononuclear cells were used freshly or were cry-
opreserved for further analysis. Isolated epithelial cells
were immediately resuspended in RLT Lysis buffer and cryo
stored until further analysis.
Flow Cytometry and FACS
For intracellular cytokine detection, cells were restimu-
lated in complete medium with phorbol 12-myristate
13-acetate (150 ng/mL; Sigma-Aldrich, St Louis, MO) and
ionomycin (750 ng/mL; Sigma-Aldrich) in the presence of
GolgiStop and Brefeldin A (BD Biosciences, Franklin Lakes,
NJ) for 4 hours at 37C in a humidifying atmosphere
(Table 5). Viability was determined by using LIVE/DEAD
Fixable Near-IR dead cell stain (Thermo Fisher, Waltham,
MA). Cell surface markers were stained extracellularly (15
min, 4C) in FACS buffer (PBS supplemented with 2% fetal
calf serum), whereas cytokines and transcription factors
were detected intracellularly using Cytofix/Cytoperm (BD
Biosciences) or Foxp3/transcription factor staining buffer
set (eBioscience, San Diego, CA), respectively. Unspecific Fcg
receptor binding was blocked by human Fc block (CD16/
CD32). Lineage cocktail for ILCs contained markers for T
cells (CD3, TCRa/b; TCRg/d), NK T cells (CD56), B cells
(CD19), dendritic cells, monocytes, MF (CD11c, CD14,
CD16), and mast cells (FcgRI). Cells were analyzed using
FACS Canto II (BD Biosciences) and FlowJo software
(TreeStar Inc, Ashland, OR). MF were sorted as viable
2021 Neuroimmune Association in HSCR Patients 537CD45þ HLAþ CD64þ using FACS Aria cell sorter flow
cytometry (BD Biosciences). Gating strategy is depicted in
Figure 15. Table 8 details the human specific antibodies.
RNA Isolation and qRT-PCR
Colonic tissue samples (maximum 30 mg) were homog-
enized in RLT lysis buffer containing 1% 2-mercaptoethanol
(Sigma-Aldrich) using a tissue disruptor (IKA). Total RNA
from tissue or cells was isolated using the RNAeasy Plus
mini kit (Qiagen) and was reverse-transcribed using
GoScript Reverse Transcription System (Promega, Madison,
WI). Subsequently, qRT-PCR was done using the ViiA7 RT-
PCR system (Thermo Fisher Scientific) and FastStart Uni-
versal SYBR Green Master (Roche Diagnostics) according to
the manufacturers’ instructions. Relative gene expression
was calculated using the 2-DCT method, with b2-
microglobulin as housekeeping gene, and results were
multiplied by a factor of 1000. Primer pairs were designed
according to exon junction span using the clone manager
software (Sci-Ed Software, Westminster, CO). Table 9 details
the human-specific primer pairs.
Generation of Blood-Derived M1 and M2 MF
Peripheral blood mononuclear cells (PBMCs) from
healthy adult volunteers were isolated using the SepMate/
Lymphoprep system (Stemcell, Vancouver, Canada) ac-
cording to the user manual. For monocyte attachment,
PBMCs were resuspended in RPMI (supplemented with
10% fetal calf serum, 200 U penicillin, and 0.2 mg/mL
streptomycin) and seeded into T-75 flasks for 2 hours at
37C in a humidifying atmosphere. The attached monocytes
were washed twice with PBS and then cultured for 10 days
in M1 or M2 Macrophage Generation Medium DXF (Pro-
moCell, Heidelberg, Germany) according to the manufac-
turer’s instructions. On day 10, cells were detached by
adding Accutase cell detachment solution (Sigma-Aldrich),
washed twice with RPMI, and used for further applications.
T-Cell Conversion Assay
Autologous naive CD4 T cells were isolated from PBMCs
using EasyStep Human naive CD4þ T cell Isolation Kit
(Stemcell) according to instruction manuals. M1 or M2 MF
(104/well/200 mL) were co-cultured with autologous naive
CD4þ T cells (105/well/200 mL) in the presence of 5 mg/mL
anti-human CD3 for 6 days at 37C in a humidifying atmo-
sphere. Alternatively, CD4þ T cells were activated using
anti-human CD3/CD28 activation Dynabeads (Life Tech-
nologies, Carlsbad, CA) in a 1:1 ratio. For T-helper cell dif-
ferentiation, we added the following cytokines: IL2 (5 ng/
mL) and TGF-b1 (2 ng/mL) for Treg conversion and TGF-b1
(2 ng/mL) and IL6 (10 ng/mL) for Th17 differentiation. All
recombinant human cytokines were purchased from
Peprotech (Rocky Hill, NJ). On day 6, T cells were separated
from MF or Dynabeads into a new well and restimulated
with phorbol 12-myristate 13-acetate (150 ng/mL) and
ionomycin (750 ng/mL) in the presence of GolgiStop and
Brefeldin A for 4 hours at 37C in a humidifying atmo-
sphere. T-cell subsets were subsequently analyzed by flowcytometry using fluorescent antibodies against human
TCRa/b, CD4, and IL17/Rorgt or CD25/Foxp3 for Th17 and
Treg cell identification. Cytokines and transcription factors
were detected intracellularly using transcription factor
buffer set (BD Biosciences) according to the manufacturer’s
instructions. Frequencies of single subsets were determined
as percentages of viable CD4/TCRa/b positive T cells. Ratios
of Th17/Treg frequencies were calculated.Immunofluorescence and Co-localization Studies
For fluorescence staining of immune cells and cholin-
ergic fibers, we established a modified protocol of the
anti-mouse HRP-AEC staining kit (R&D). All steps were
performed at room temperature. Between all steps, the
tissues were washed 3 times for 10 minutes in PBS, and
antibodies/streptavidin/40,6-diamidine-20-phenylindole
dihydrochloride (DAPI) were diluted in antibody diluent.
Briefly, cryosections (5 mm) were fixed with 4% para-
formaldehyde for 5 minutes, followed by a blocking step
with serum blocking reagent (15 minutes). Subsequently,
avidin and biotin were blocked using Avidin Blocking
Reagent (15 minutes), followed by Biotin Blocking Reagent
(15 minutes). Primary antibodies were incubated for 1 hour
and secondary antibodies for 45 minutes at room temper-
ature. CD64, AChE, beta3tubulin, TH, nNOS, S100b, and
VAChT were detected by secondary antibodies goat anti-
mouse IgG1, IgG2a, or IgG2b labeled with A488, A555,
A647, or biotin, as indicated. VIP was detected by anti-
guinea pig A555. IL23p19 was directly phycoerythrin-
labeled, and CD3 was directly A488-labeled. Biotin was
visualized by streptavidin-Cy3 incubation for 30 minutes.
Finally, nuclei were visualized by DAPI staining (3 minutes;
0.5 mg/mL), and slides were mounted using Prolong Dia-
mond Antifade Mountant (Life Technologies). Secondary
antibody controls were included as negative controls. Im-
ages were taken by a fluorescence microscope (BX43
Olympus) and analyzed using CellSense (Olympus) and Fiji.
Table 8 details the antibodies used for histology. Fast-
scanning confocal microscopy was performed with a Zeiss
(Oberkochen, Germany) LSM880 Airyscan inverted sys-
tem. Images were acquired and processed using Zen Black
with a 63 plan apochromatic oil immersion objective
DIC M27(NA1.4) using the 3 respective Ar-lasers 561 nm,
488 nm, and 405 nm in 4 frames average fast mode. The
acquisition parameters and settings of the images were
verified for the absence of crosstalk between Green and
Red excitation, and gain of the different lasers was always
set at the same values for all acquisitions. Negative
staining controls (secondary antibodies only) were used
to determine pixel intensity background for the quantifi-
cation. Images of high-fiber and low-fiber tissues were
used for acquisition. Using a Fiji software macro, we
quantified the co-localization pixel intensity between MF
(or T cells) and AChE fibers. Briefly, images were created
by multiplying and subsequent automated thresholding of
the respective channels. Regions of interest containing MF
(or T cells) were manually annotated in the raw data. The
sums of co-localized pixel values contained within
Figure 15. Gating strategy for flow cytometric analysis and cell sorting. (A–D) Representative gating strategies for FACS
analysis of LP mononuclear cells from HSCR and control patients. (A) Th17 cells were evaluated in viable CD3þ CD4þ lym-
phocytes restimulated with phorbol 12-myristate 13-acetate (PMA)/ionomycin in the presence of GolgiStop and Brefeldin A.
Unstimulated lymphocytes (Golgi-stop/Brefeldin A only) served as negative control. (B) CD127-Foxp3þ Tregs were gated in
viable CD3þ CD4þ lymphocytes. (C) Subsets of ILC3 were detected in viable lin-CD127þ CD161þ CRTH2- lymphocytes. ILC3
NCRþ were defined as c-kitþNKp46þ and ILC3 NCR- as c-kitþNKp46-. (D) Macrophage gating strategy for FACS analysis as
well as for cell sorting. HLAþ CD64þ macrophages were detected in viable CD45þ leukocytes.
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were measured on a sum projection image. Data are
shown as raw integrated density.For the quantification of IL23, images recorded under a
20 objective were analyzed using CellSense Software
(Olympus) and Cellprofiler-3.1.9. To quantify IL23þ MF in
Table 8.Antibodies for FACS and Histology
Name Clone Fluorocrome Supplier Catalog no. RRID
Antibodies for flow cytometry
CD3 SK7 PerCP BioLegend 344814 AB_10639948
HLA-DR L243 FITC eBioscience 11-9952-42 AB_2572542
CD45 HI30 APC BD Biosciences 555485 AB_398600
CD14 HCD14 PerCP BioLegend 325632 AB_2563328
CD64 10.1 PE-Cy7 BioLegend 305022 AB_2561584
CD11c 3.9 Alexa700 eBioscience 56-0116-42 AB_10547281
CD4 RPA-T4 FITC BD Biosciences 555346 AB_395751
CD127 A019D5 PE BioLegend 351304 AB_10720185
CD25 BC96 Alexa 647 BioLegend 302618 AB_493045
NKp44 p44-8 BB515 BD Biosciences 565099 AB_2739067
CD11c 3.9 PerCP/Cy5.5 BioLegend 301624 AB_10640733
CD19 HIB19 PerCP BioLegend 302228 AB_893272
CD56 HCD56 PerCP BioLegend 318342 AB_2561865
FcεRI AER-37 PerCP Novus Biologicals NBP1-43278PCP AB_10006605
TCR a/b IP26 PerCP/Cy5.5 BioLegend 306724 AB_2563002
TCR g/d B1 PerCP/Cy5.5 BioLegend 331224 AB_2563013
CD117 (c-kit) 104D2 APC BioLegend 313206 AB_314985
CD294 (CRTH2) BM16 PE-Cy7 BioLegend 350118 AB_2562470
CD161 HP-3G10 Alexa 700 BioLegend 339942 AB_2565870
IL17A eBio64DEC17 APC eBioscience 17-7179-42 AB_1582221
IFN-g B27 Alexa 700 BioLegend 506516 AB_961351
Rorgt Q21-559 Alexa 488 BD Biosciences 563621 AB_2738325
Foxp3 PCH101 PE-Cy7 eBioscience 25-4776-42 AB_10804638
CD16/CD32 (Fc block) purified BD Biosciences 564219 AB_2728082
Name Clone Fluorocrome Host-subtype Supplier Catalog no. RRID
Primary antibodies for histology
CD64 10.1 purified mouse IgG1 BioLegend 305002 AB_314486
CD3 UCHT1 Alexa 488 mouse IgG1 BioLegend 300454 AB_2564149
AChE HR2 purified mouse IgG2b Abcam ab2803 AB_303316
Beta III tubulin 2G10 purified mouse IgG2a Abcam ab78078 AB_2256751
Beta III tubulin GT11710 purified mouse IgG2b Genetex GTX631836 AB_2814952
TH 1A5 purified mouse IgG2a Invitrogen MA1-24654 AB_795666
nNOS 16/nNOS/NOS type I purified mouse IgG2a BD Bioscience 610308 AB_397700
S100b 11C12E12 purified mouse IgG1 BioLegend 676603 AB_2734531
VIP polyclonal purified guinea pig Peninsula
Laboratories
sc-25347 AB_628439
VAChT S6-38 purified mouse IgG1 Thermo Fisher Scientific MA5-27662 AB_2735407
IL23p19 23dcdp PE mouse IgG2b eBioscience 12-7823-41 AB_10669562
2021 Neuroimmune Association in HSCR Patients 539tissues of different patient groups (4 low-fiber, 4 high-fiber),
4–8 regions per patient from rectum and sigmoid colon were
used. Primary objects were defined by nuclear DAPI staining.
Secondary object was defined by extracellular CD64 expres-
sion using the watershed module after applying a globalTable 9.List of Primers
Gene Forward sequence 50-30
AChE CAT CTT TGG GAT CCC CCT G
CX3CR1 CAT CGT GGT CTT TGG GAC
CCR2 ATA CCA GGA CTG CCT GAG
Occludin ATG GAC TGC GTC ACG CAG
ZO-1 AGC ACA GCA ATG GAG GAA
b2M CAG CGT ACT CCA AAG ATT Cthreshold for improved cell identification. IL23þ cells were
identified as a second primary object (IL23þ), using Three
classes Otsu thresholding method and subsequently related
to CD64 MF. Frequencies of IL23þ MF (IL23þ CD64þ) were
shown as the percentage of total MF.Reverse sequence 50-30
G TCA TTG GGA TCC CCT GTG C
TG TTG GTG AGG GCA AAC ACT AC
AC CGC TCT CGT TGG TAT TTC TG
AG CCA CAA ACA TGG CCA GGA AG
AC GGT CCT CCT TTC AGC ACA TC
A GAA TGC TCC ACT TTT TCA AT
Table 10.Statistical Analysis of Protein Expression

















0.0203a 0.0874 0.0699 0.2455 0.5744 0.0173a 0.3571 0.0085a 0.091 0.4842 0.4998
Fiber-low vs DC
AG
0.0051a 0.0846 0.1079 0.5821 0.4535 0.5086 0.6999 0.0767 0.6356 0.0934 0.5709
Fiber-low vs DC
G
0.015a 0.1208 0.1874 0.0809 0.8556 0.5149 0.0905 0.0686 0.0498a 0.7638 0.8804
Fiber-low vs DC
control
0.0875 0.2958 0.244 0.8351 0.9763 0.1437 0.7554 0.0984 0.3886 0.7609 0.7651
Fiber-high vs DC
AG
0.5211 0.0046a 0.9658 0.6409 0.8335 0.0128a 0.2791 0.5518 0.072 0.045a 0.9649
Fiber-high vs DC
G
0.773 0.008a 0.762 0.5306 0.7657 0.1685 0.4438 0.5831 0.7046 0.4274 0.68
Fiber-high vs DC
control
0.9386 0.0432a 0.9276 0.5975 0.7073 0.8401 0.7589 0.8482 0.776 0.8665 0.8737
DC AG vs DC G 0.7391 0.9554 0.8068 0.3049 0.6322 0.2763 0.0845 0.9652 0.0411a 0.2494 0.7288
DC AG vs DC
control
0.6751 0.8678 0.9567 0.8651 0.606 0.0812 0.5897 0.7844 0.2784 0.1417 0.9053
DC G vs DC
control







DC AG vs muscle 0.0026a 0.1371 0.053




Luminex analysis IL17 IL22 IL6 IL1b IL23 TNF-a IFN-g
Fiber-low vs fiber-high 0.1902 0.6819 0.1494 0.3519 0.2586 0.4577 0.7052
Fiber-low vs DC AG 0.2889 0.9629 0.5148 0.1978 0.4495 0.3657 0.664
Fiber-low vs DC G 0.5562 0.2818 0.1644 0.4058 0.7027 0.1131 0.4937
Fiber-low vs DC control 0.8747 0.4205 0.7879 0.872 0.6957 0.5716 0.9371
Fiber-high vs DC AG 0.0485a 0.7042 0.0815 0.0634 0.1215 0.1671 0.4962
Fiber-high vs DC G 0.5552 0.5609 0.9919 0.9494 0.2245 0.4559 0.7873
Fiber-high vs DC control 0.4928 0.3191 0.2469 0.6592 0.8588 0.9599 0.7455
DC AG vs DC G 0.1694 0.3471 0.0893 0.0783 0.7738 0.039a 0.3523
DC AG vs DC control 0.4097 0.4829 0.8616 0.3299 0.4575 0.2751 0.8219
DC G vs DC control 0.8142 0.1568 0.2554 0.6977 0.576 0.6088 0.5919
aStatistically significant value.
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Immunosorbent Assays
Colonic tissues samples were homogenized in Tissue
Extraction Reagent I (100 mL/10 mg; ThermoFisher) con-
taining protease inhibitor cocktail (Sigma-Aldrich) using a
tissue disruptor (IKA). Concentrations (pg/mL) of IL6, IL22,
IL1b, TNF-a, and IL17 were determined using MILLI-
PLEXMAP Human Cytokine/Chemokine/Growth Factor Panel
A Assay (Millipore Sigma, St Louis, MO) and Luminex xMAP
technology (MAGPIX) according to the manufacturers’instructions. Samples were measured using xPONENT for
MAGPIX software. IL23 was determined in tissue lysates
using Human IL-23 ELISA Ready-Set-Go according to the
manufacturer’s instructions. IL-23 ELISA was measured
using a Synergy H4 Hybrid Reader and GEN5 2.00 software
(BioTek, Winooski, VT).
16S rRNA FISH
The FISH procedure was performed in 5-mm rectum/
sigmoid colon Swiss roll cryosections. We used Cy3-labeled
2021 Neuroimmune Association in HSCR Patients 541EUB338 probe (GCT GCC TCC CGT AGG AGT) complemen-
tary to bacteria-specific 16S rRNA region as well as NON338
probe (ACT CCT ACG GGA GGC AGC), an oligonucleotide
complementary to the probe EUB338, to control for
nonspecific binding. Colonic tissue sections were fixed with
4% paraformaldehyde for 20 minutes on ice, followed by a
wash step in PBS. Slides were dipped into ice-cold methanol
before hybridization in hybridization buffer (20 mmol/L
Tris-HCl, 0.9% NaCl, 0.1% sodium dodecyl sulfate) at 48C
for 16 hours. Slides were washed twice in hybridization
wash buffer (20 mmol/L Tris-HCl, 0.9% NaCl, pH 7.2) for 30
minutes at 48C and subsequently mounted with ProLong
Gold Antifade Mountant with DAPI (Life Technologies) and
evaluated with a fluorescence microscope (BX43 Olympus).
Images were analyzed using CellSense Software (Olympus)
and Fiji software. To quantify the bacterial translocation in
the different patient groups, 4–6 regions per picture from
rectum and sigmoid colon were used, and corresponding
sites were used for anti-sense probe. On average, 2000
DAPIþ cells/region were then processed using Cellprofiler
software. In brief, primary objects were defined by nuclear
DAPI staining. After masking the nuclei, a second primary
object (Eub338_bacteria) based on nuclear Eub338
expression was defined and related to DAPIþ cells. Global
Otsu two classes thresholding method was applied for DAPI
nuclei staining, and manual thresholding for Eub338 was
used before masking the nuclei to subtract the background.
The anti-sense probe was running in parallel under the
same pipeline, and results were subtracted from the sense
probe. Frequencies of translocated bacteria (16S rRNAþ/
DAPIþ) were expressed as the percentage of total DAPIþ
cells.16S rDNA Gene Sequencing
For 16S rDNA microbial analysis, we used colonic cry-
osections (100 mm). Extraction, lysis, and DNA isolation
were done using Fast DNA Stool Mini Kit (Qiagen) according
to the manufacturer’s instructions. Bead beating was run on
a fastprep24 instrument (MP Biomedicals, Santa Ana, CA; 2
cycles of 45 seconds at speed 4, followed by 2 cycles of 45
seconds at speed 5) in 2 mL screwcap tubes containing 0.1
mm zirconia beads (0.3 g) and 2.3 mm zirconia beads (0.36
g). The whole raw extract was prepared for DNA isolation.
Concentration of the isolated DNA was determined with
PicoGreen measurement (Quant-iT PicoGreen dsDNA Assay
Kit; Thermo Fisher), and integrity was checked by agarose
gel electrophoresis.
The Illumina MiSeq (San Diego, CA) platform and a v2
500 cycles kit were used to sequence the PCR libraries.
The produced paired-end reads that passed Illumina’s
chastity filter were subjected to de-multiplexing and
trimming of Illumina adaptor residuals using Illumina’s
real-time analysis software included in the MiSeq reporter
software v2.6 (no further refinement or selection). The
quality of the reads was checked with the software FastQC
version 0.11.7. The locus-specific V34 primers were trim-
med from the sequencing reads with the software Cuta-
dapt v1.14. Paired-end reads were discarded if the primercould not be trimmed. Trimmed-forward and reverse reads
of each paired-end read were merged to reform the
sequenced molecule in silico, considering a minimum
overlap of 15 bases using the software USEARCH version
10.0.240. Merged sequences were then quality-filtered,
allowing a maximum of one expected error per merged
read and also discarding those containing ambiguous ba-
ses. The remaining reads were denoised using the UNOISE
algorithm implemented in USEARCH to form OTUs dis-
carding singletons and chimeras in the process. OTUs were
compared with the reference sequences of the SILVA 16S
database, and taxonomies were predicted considering a
minimum confidence threshold of 0.6 using the SINTAX
algorithm implemented in USEARCH. Alpha diversity was
estimated using the Richness (Observed), Shannon and
Simpson indices. Beta diversity was calculated using the
Unifrac distance method on the basis of normalized OTU
abundance counts per sample. These sample distances
were then used in a detrended correspondence analysis to
reveal possible patterns of intersample relations. Alpha
and beta diversity calculations and the rarefaction analysis
were performed with the R software package phyloseq
v1.22.3. To detect differentially abundant OTUs depending
on collected sample metadata (eg, medication, environ-
mental conditions), differential OTU analysis on normal-
ized abundance counts was performed with the R software
package DESeq2 v1.18.1. Libraries, sequencing, and data
analysis described in this section were performed by
Microsynth AG (Balgach, Switzerland).RNA-seq Analysis
FACS sorted viable MF (300–3000 cells) as well as
blood-derived M1 and M2 MF (100,000 cells) were used for
RNA-seq analysis. RNA was isolated using RNeasy micro kit
(Qiagen). RNA samples were quantified using Qubit 2.0
Fluorometer (Life Technologies), and RNA integrity was
checked with Agilent TapeStation (Agilent Technologies,
Palo Alto, CA). RNA library preparations, sequencing re-
actions, and initial bioinformatics analysis were conducted
at GENEWIZ, LLC (South Plainfield, NJ). The SMART-Seq v4
Ultra Low input kit for sequencing was used for full-length
cDNA synthesis and amplification (Clontech, Mountain View,
CA) according to the manufacturer’s protocol. Illumina
Nextera XT library was used for library preparation. Briefly,
cDNA was fragmented, and adaptors were added using
transposase, followed by limited-cycle PCR to enrich and
add index to the cDNA fragments. Final libraries were
analyzed on the Agilent TapeStation for library sizing and
quantified using the Qubit dsDNA HS assay kit and by qPCR
using the KAPA library quantification kit. The sequencing
libraries were multiplexed and clustered on 2 lanes of a flow
cell. After clustering, the flow cell was loaded on the Illu-
mina HiSeq instrument according to the manufacturer’s in-
structions. The samples were sequenced using a 2150
Paired End configuration. Image analysis and base calling
were conducted by the HiSeq Control Software (HCS). Raw
sequence data (.bcl files) generated from Illumina HiSeq
were converted into fastq files and de-multiplexed using
542 Keck et al Cellular and Molecular Gastroenterology and Hepatology Vol. 12, No. 2Illumina’s bcl2fastq 2.17 software. One mismatch was
allowed for index sequence identification. After investi-
gating the quality of the raw data, sequence reads were
trimmed to remove possible adapter sequences and nucle-
otides with poor quality using Trimmomatic v.0.36. The
trimmed reads were mapped to the human reference
genome available on ENSEMBL using the STAR aligner
v.2.5.2b. The STAR aligner uses a splice aligner that detects
splice junctions and incorporates them to help align the
entire read sequences. BAM files were generated as a result
of this step. Unique gene hit counts were calculated by using
featureCounts of the Subread package v.1.5.2. Only unique
reads that fell within exon regions were counted. After
extraction of gene hit counts, the gene hit counts table was
used for downstream differential expression analysis. All
statistical analyses were performed using R project soft-
ware. Comparison of gene expression between the groups of
samples was performed with the package DESeq2. The Wald
test was used to generate P values and log2 fold changes.
Genes with adjusted P values <.05 and absolute log2 fold
changes >1 were regarded as differentially expressed genes
for each comparison. The statistically significant set of genes
was subjected to a gene ontology analysis by implementing
the software GeneSCF. The mgi GO list was used to cluster
the set of genes on the basis of their biological process and
to determine their statistical significance. A PCA was per-
formed using the plotPCA function of the DESeq2 R package.
The plot shows the samples in a 2-dimensional plane
spanned by their first 2 principal components. The top 500
genes, selected by highest row variance, were used to
generate the plot.
Statistical Analysis
Data were analyzed using Prism GraphPad (San Diego,
CA) 6.0 software and Stata (StataCorp 2015, Stata Statistical
Software: Release 15; College Station, TX). Data are reported
as the means ± standard error of the mean. Statistical sig-
nificance was determined using one-way analysis of vari-
ance multiple comparison analysis, unpaired nonparametric
two-tailed Mann-Whitney test, and unpaired t test (for M1/
M2 MF). Differences were considered statistically signifi-
cant with *P  .05, **P  .01, ***P  .001, and ****P 
.0001. Unless otherwise noted, figures show pooled patient
data from several independent experiments or a represen-
tative of repeated experiments. The characteristics and risk
factors of study participants were compared between low-
fiber versus high-fiber HSCR patient groups and between
subjects with enterocolitis versus no enterocolitis during
follow-up by using two-sided Wilcoxon rank-sum test and
c2 test, as appropriate.
Data Availability
The data sets generated and analyzed during the current
study have been deposited in NCBI Sequence Read Archive
under the accession code PRJNA552657 (RNA-seq datasets)
and PRJNA550537 (16S rDNA datasets). All other study-
related data are available from the corresponding author
upon reasonable request.All authors had access to the study data and reviewed
and approved the final manuscript.
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